Spektrum płodowego alkoholowego zaburzenia rozwoju
Epidemiologia

Spektrum płodowego alkoholowego zaburzenia rozwoju (FASD) obejmuje zaburzenia neurozwojowe wynikające z prenatalnej ekspozycji na alkohol, charakteryzujące się dysmorfią twarzy, zaburzeniami wzrostu, deficytami OUN oraz zaburzeniami poznawczymi i behawioralnymi. Globalna częstość występowania FASD wynosi około 7,7/1000 (0,77%), z najwyższymi wskaźnikami w regionie europejskim WHO (19,8/1000) i znacznym zróżnicowaniem geograficznym. W USA szacuje się, że 1-5% dzieci w wieku szkolnym może mieć FASD, a w niektórych regionach Południowej Afryki, Chorwacji i Irlandii wskaźniki sięgają odpowiednio 111,1, 53,3 i 47,5/1000. Diagnostyka FASD jest utrudniona przez brak jednolitych kryteriów, częstość występowania cech fizycznych ograniczoną do cięższych postaci oraz niedoszacowanie przypadków z powodu stygmatyzacji i trudności w potwierdzeniu ekspozycji na alkohol. Wczesna diagnoza i interdyscyplinarne podejście są kluczowe dla optymalizacji wyników klinicznych.

Epidemiologia spektrum płodowego alkoholowego zaburzenia rozwoju

Spektrum płodowego alkoholowego zaburzenia rozwoju (FASD) stanowi zbiór zaburzeń neurozwojowych, które mogą wystąpić u osób narażonych na działanie alkoholu w okresie prenatalnym. FASD charakteryzuje się szeregiem objawów, które mogą obejmować specyficzne cechy dysmorficzne twarzy, zaburzenia wzrostu, nieprawidłowości ośrodkowego układu nerwowego oraz zaburzenia poznawcze i behawioralne.12 Jest to jedna z głównych, możliwych do uniknięcia, przyczyn niepełnosprawności intelektualnej i zaburzeń rozwojowych na świecie.34

Globalne rozpowszechnienie FASD

Według danych z metaanaliz, globalna częstość występowania spektrum płodowego alkoholowego zaburzenia rozwoju szacowana jest na około 7,7 przypadków na 1000 osób (0,77%).123 Występowanie FASD wykazuje znaczne zróżnicowanie geograficzne. Najwyższe wskaźniki odnotowuje się w regionie europejskim Światowej Organizacji Zdrowia (WHO), gdzie szacunki wskazują na 19,8 przypadków na 1000 osób, natomiast najniższe wartości występują w regionie wschodniego basenu Morza Śródziemnego (0,1 na 1000).4 Różnice te korelują z poziomem spożycia alkoholu przez kobiety w ciąży w poszczególnych regionach świata.5

Wyższe wskaźniki FASD obserwuje się w krajach Europy i Ameryki Północnej, gdzie częstość występowania szacuje się na poziomie 1-5% populacji.67 W obszarach wysokiego ryzyka, takich jak niektóre regiony Południowej Afryki, Chorwacji czy Irlandii, szacunkowe wskaźniki FASD są znacznie wyższe i wynoszą odpowiednio 111,1, 53,3 i 47,5 przypadków na 1000 osób.8

Rozpowszechnienie FASD w Stanach Zjednoczonych

W Stanach Zjednoczonych częstość występowania FASD jest szacowana na różnych poziomach, w zależności od zastosowanej metodologii badawczej. Badania oparte na analizie dokumentacji medycznej wskazują na występowanie pełnoobjawowego zespołu alkoholowego płodu (FAS) na poziomie 0,2-1,5 przypadków na 1000 żywych urodzeń.910 Natomiast badania wykorzystujące bezpośrednią ocenę dzieci w wieku szkolnym sugerują wyższe wskaźniki FAS, wynoszące 6-9 przypadków na 1000 dzieci.11

Najnowsze badania przeprowadzone przez National Institutes of Health, wykorzystujące badania fizykalne dzieci w wieku szkolnym, wskazują, że pełne spektrum FASD w Stanach Zjednoczonych może dotyczyć od 1% do 5% populacji dzieci w wieku szkolnym.1213 Przełomowe badanie opublikowane w Journal of the American Medical Association w 2018 roku, wykorzystujące metodę badań szkolnych (uznawana za złoty standard nadzoru zdrowia publicznego), potwierdziło, że do 5% amerykańskich dzieci może być dotkniętych FASD, co stanowi znacznie dokładniejsze oszacowanie niż wcześniejsze badania.1415

Centra Kontroli i Zapobiegania Chorób (CDC) monitorują częstość występowania FAS w dwóch programach nadzoru wad wrodzonych. Dane z Metropolitalnego Programu Wad Wrodzonych w Atlancie (MACDP) wskazują, że obserwowana częstość występowania pełnoobjawowego FAS wśród dzieci urodzonych w Atlancie w latach 1981-1989 wynosiła 1,0 przypadek na 10 000 żywych urodzeń, a łącznie FAS i częściowego FAS – 2,5 przypadku na 10 000.16

Rozpowszechnienie FASD w innych krajach

W Kanadzie, według danych z Kanadyjskiego Badania Zdrowia Dzieci i Młodzieży z 2019 roku, częstość występowania zdiagnozowanego FASD wśród dzieci i młodzieży w wieku 1-17 lat oszacowano na 1 na 1000 (0,1%). Wskaźnik ten był znacząco wyższy wśród osób identyfikujących się jako ludność rdzenna mieszkająca poza rezerwatami (1,2%).1718

W Wielkiej Brytanii do niedawna brakowało wiarygodnych oszacowań rozpowszechnienia FASD. Pierwsze krajowe badanie mające na celu określenie skali problemu, opublikowane w 2018 roku, wskazało na częstość występowania FASD w zakresie od 6% do 17%.1920 Badanie przeprowadzone w szkołach podstawowych w Greater Manchester w 2019 roku było pierwszym brytyjskim badaniem wykorzystującym metodę aktywnego ustalania przypadków, uznawaną za najbardziej wiarygodne podejście do oceny rozpowszechnienia.21

W Australii prowadzony jest aktywny nadzór nad FASD poprzez Australijską Jednostkę Nadzoru Pediatrycznego oraz Australijski Rejestr FASD. Wcześniejsze badania wskazywały, że australijscy klinicyści nie byli wystarczająco przygotowani lub niechętni do diagnozowania FASD i nie wiedzieli, gdzie kierować pacjentów w celu oceny lub zarządzania FASD, co skłoniło rząd do finansowania wytycznych diagnostycznych.22

Czynniki ryzyka i wzorce spożycia alkoholu

Najważniejszym znanym czynnikiem ryzyka rozwoju FASD jest ekspozycja na alkohol w okresie prenatalnym.23 Ryzyko FASD wzrasta wraz z ilością spożywanego alkoholu, częstością jego spożywania oraz dłuższym czasem spożywania alkoholu podczas ciąży, szczególnie w przypadku epizodycznego intensywnego picia (binge drinking).24

Według danych z Centrów Kontroli i Zapobiegania Chorób, odsetek kobiet w ciąży spożywających alkohol wzrósł z 7,6% w 2012 roku do 10,2% w 2015 roku, a liczba kobiet w ciąży zgłaszających epizodyczne intensywne picie (co najmniej cztery napoje alkoholowe jednorazowo) wzrosła z 1,4% do 3,1%.25 W szerszym kontekście, około 25% mężczyzn i kobiet w wieku 18-34 lat uprawia epizodyczne intensywne picie alkoholu, a 73% ciąż jest narażonych na działanie alkoholu.26

Do czynników ryzyka matczynych dla FASD należą: ogólny stan zdrowia fizycznego i psychicznego kobiety, rodzaj, ilość, częstotliwość i czas ekspozycji na alkohol w okresie ciąży, a także normy i praktyki społeczne.27 Badanie włoskie przeprowadzone wśród 992 kobiet w ciąży zidentyfikowało następujące czynniki ryzyka ciąż narażonych na działanie alkoholu: młodszy wiek (poniżej 30 lat), nieplanowana ciąża, bezrobocie, niższe wykształcenie i bycie singlem.28

FASD w populacjach wrażliwych

Częstość występowania FASD może być do 40 razy wyższa w określonych subpopulacjach niż w populacji ogólnej. Niedawny systematyczny przegląd i metaanaliza wykazały podwyższone rozpowszechnienie FASD wśród dzieci objętych opieką zastępczą, w zakładach poprawczych, w programach edukacji specjalnej oraz w specjalistycznych placówkach klinicznych.29

W Stanach Zjednoczonych FASD występuje najrzadziej wśród dzieci pochodzenia latynoskiego, a najczęściej wśród rdzennych Amerykanów i rdzennych mieszkańców Alaski.30 Dane CDC wskazują, że ogólny wskaźnik FAS wynosił 2,97 na 1000 dla rdzennych Amerykanów, 0,6 na 1000 dla Afroamerykanów, 0,09 dla osób rasy białej, 0,08 dla Latynosów i 0,03 dla Azjatów.31

Niezależnie od rasy czy pochodzenia etnicznego, FAS i FASD występują u kobiet, które piją duże ilości alkoholu w czasie ciąży. Częstość występowania FAS wydaje się być najwyższa wśród grup o niskim statusie społeczno-ekonomicznym.32

Wyzwania w nadzorze i diagnostyce FASD

Nadzór nad FASD napotyka na liczne wyzwania, które utrudniają dokładne określenie rozpowszechnienia tego zaburzenia w populacji. Zrozumienie tych wyzwań jest kluczowe dla opracowania skutecznych strategii nadzoru i poprawy identyfikacji przypadków FASD.

Trudności diagnostyczne

Diagnoza FASD jest złożona i wymaga oceny wielodyscyplinarnego zespołu specjalistów, którzy analizują wzrost, cechy twarzy, funkcjonowanie ośrodkowego układu nerwowego oraz ekspozycję na alkohol.33 Brak jednolitych, międzynarodowych kryteriów diagnostycznych FASD stanowi istotne wyzwanie, z ponad dziesięcioma różnymi kryteriami diagnostycznymi stosowanymi na całym świecie.34

FASD często pozostaje nierozpoznane lub jest błędnie diagnozowane, co sprawia, że interwencje są bardziej wymagające lub opóźnione.35 FAS diagnozowany jest średnio w wieku 48,3 miesięcy, jednak często jest pomijany lub błędnie diagnozowany, co uniemożliwia dzieciom otrzymanie potrzebnych usług w odpowiednim czasie.36

Większość osób z FASD nie wykazuje charakterystycznych cech fizycznych, co sprawia, że jest to „ukryta niepełnosprawność”.37 Tylko diagnozy na poważniejszym końcu spektrum FASD (tj. FAS i częściowy FAS) charakteryzują się fizycznymi cechami twarzy. Większość dzieci dotkniętych alkoholem nie posiada niektórych lub wszystkich tych markerów fizycznych i dlatego jest trudniejsza do zidentyfikowania, zwłaszcza jeśli nie jest dostępna jednoznaczna historia ekspozycji na alkohol.38

Metody nadzoru i ich ograniczenia

Obecnie stosowane metody wykrywania FAS i FASD mogą prowadzić do niedoszacowania rozpowszechnienia i identyfikować jedynie najpoważniejsze przypadki.39 Nadzór nad FASD jest podobny do nadzoru nad innymi zaburzeniami rozwojowymi, jednak ponieważ FAS jest złożoną diagnozą, może pozostać nierozpoznany przy urodzeniu.40

Istnieją trzy główne typy danych wykorzystywanych do szacowania częstości występowania FAS i FASD:41

  • Informacje zbierane pasywnie w innym celu, takie jak rejestry wad wrodzonych42
  • Informacje gromadzone retrospektywnie lub prospektywnie z populacji szpitali lub klinik, w tym badania kontrolowane dotyczące wpływu matczynego nadużywania substancji43
  • Aktywne ustalanie przypadków oparte na populacji44

Oszacowania oparte na rejestrach mogą prowadzić do znacznego niedoszacowania częstości występowania FASD.45 Z badań klinicznych można wywnioskować, że częstość występowania FAS różni się w zależności od częstości występowania problemu w wybranej populacji obsługiwanej przez szpital lub klinikę oraz od metodologii stosowanej do identyfikacji i ustalenia przypadku.46

Epidemiologiczne badania populacyjne wykorzystujące aktywne ustalanie przypadków mogą pomóc w rozwiązaniu niektórych z wymienionych problemów, dostarczyć istotnych informacji na temat skali problemu w określonych społecznościach i być bardziej przydatne dla kompleksowych, opartych na społeczności działań prewencyjnych.47

Wiek w momencie diagnozy a nadzór

Badania wskazują, że dzieci były identyfikowane jako mające potwierdzony lub prawdopodobny FAS krótko po swoich czwartych urodzinach.48 Implikacją tego odkrycia dla nadzoru nad zespołem alkoholowym płodu jest to, że znaczna ilość czasu po urodzeniu powinna być przeznaczona na oszacowanie rzeczywistego rozpowszechnienia.49

Metodologicznie, aktywne działania nadzorcze mogą być najlepiej dostosowane do kohort urodzeniowych z jednego roku z ustalonym czasem ustalania przypadków lub ustalania przypadków w określonym wieku.50 Działania nadzorcze nad FASD powinny obejmować analizę dokumentacji dzieci, które są znacznie starsze niż jest to typowe w nadzorze nad wadami wrodzonymi.51

Niedodiagnozowanie i niedoszacowanie FASD

Wskaźniki występowania FAS i FASD są prawdopodobnie niedoszacowane ze względu na trudności w postawieniu diagnozy i niechęć klinicystów do etykietowania dzieci i matek.52 Brak spójności w wiadomościach dotyczących profilaktyki, stosowaniu wytycznych diagnostycznych w różnych grupach socjodemograficznych oraz brak perspektywy redukcji szkód w podejściach do badań przesiewowych stanowią dodatkowe wyzwania.53

Wykrywanie spożycia alkoholu jest trudne ze względu na stygmatyzację społeczną i jest szczególnie wrażliwe podczas przeprowadzania wywiadów z kobietami w ciąży.54 Ten problem jest dodatkowo pogłębiany przez niedodiagnozowanie i niedostateczne zgłaszanie przypadków FASD.55

Wpływ FASD na zdrowie publiczne

FASD stanowi istotne wyzwanie dla zdrowia publicznego, generując znaczące obciążenia zarówno dla jednostek dotkniętych tym zaburzeniem, jak i dla całego społeczeństwa. Zrozumienie pełnego zakresu konsekwencji FASD jest kluczowe dla opracowania skutecznych strategii zapobiegania i interwencji.

Obciążenie ekonomiczne

FASD wiąże się ze znacznym obciążeniem ekonomicznym. Szacunkowy koszt opieki nad jedną osobą z FAS w 2002 roku wynosił 2 miliony dolarów.56 Szacuje się, że koszt samego FAS dla Stanów Zjednoczonych przekracza 4 miliardy dolarów rocznie.57

W Stanach Zjednoczonych szacunkowy dodatkowy koszt FAS w okresie 20 lat został oszacowany na 500 000 dolarów na osobę.58 Te koszty obejmują opiekę medyczną, edukację specjalną, usługi społeczne, umieszczanie w placówkach opiekuńczych oraz kontakty z systemem wymiaru sprawiedliwości.59

Długoterminowe konsekwencje

Osoby z FASD mogą doświadczać problemów trwających całe życie.60 FASD trwa przez całe życie i nie ma na nie lekarstwa.61 Obciążenie związane z FASD obejmuje długotrwałą niepełnosprawność fizyczną i poznawczą, zaburzenia behawioralne, współwystępowanie chorób psychiatrycznych i somatycznych, zmniejszoną produktywność, bezrobocie, bezdomność i uwięzienie.62

Badania wykazały, że w okresie dojrzewania mogą wystąpić następujące wtórne niepełnosprawności:63

  • Problemy ze zdrowiem psychicznym (90%)64
  • Problemy z prawem (60%)65
  • Niska wydajność szkolna i porzucenie nauki (60%)66
  • Nieodpowiednie zachowania seksualne (49%)67
  • Problemy z alkoholem i narkotykami (33%)68

FASD jest związane z licznymi zaburzeniami neurobehawioralnymi, w tym niższą ogólną inteligencją i deficytami w funkcjonowaniu wykonawczym, uczeniu się i pamięci, języku, funkcjonowaniu wzrokowo-przestrzennym i uwadze.69 Dzieci z FASD wykazują deficyty w umiejętnościach życia codziennego i są bardziej narażone na problemy behawioralne.70

Strategie zapobiegania

FASD jest w pełni możliwe do zapobieżenia, jeśli dziecko nie jest narażone na działanie alkoholu przed urodzeniem.71 CDC, Amerykańska Akademia Lekarzy Rodzinnych, Amerykańska Akademia Pediatrii i Amerykańskie Kolegium Położników i Ginekologów uznają, że nie istnieje bezpieczna ilość spożycia alkoholu podczas ciąży i zalecają całkowitą abstynencję.72

Nie ma bezpiecznej ilości alkoholu, która byłaby uznana za bezpieczną na jakimkolwiek etapie ciąży.73 Nie ma bezpiecznych ram czasowych do picia alkoholu podczas ciąży lub podczas starań o zajście w ciążę.74 Nie ma bezpiecznego rodzaju alkoholu do używania podczas ciąży lub podczas starań o zajście w ciążę.75

Wczesne wykrycie spożywania alkoholu podczas ciąży ma kluczowe znaczenie zarówno ze względu na swoje implikacje zapobiegawcze, jak i terapeutyczne.76 Zalecenia specjalistów i wczesna identyfikacja kobiet z grupy ryzyka mają kluczowe znaczenie, ponieważ skutki działania alkoholu na płód można w 100% zapobiec poprzez wstrzymanie spożywania alkoholu w okresie prekoncepcyjnym i w czasie ciąży.77

Systemy nadzoru nad FASD

Skuteczne systemy nadzoru nad FASD są niezbędne do monitorowania wzorców występowania tego zaburzenia oraz oceny wpływu działań prewencyjnych. Różne kraje i regiony opracowały różnorodne podejścia do nadzoru nad FASD.

Istniejące systemy nadzoru

Centra Kontroli i Zapobiegania Chorób monitorują częstość występowania FAS w dwóch programach nadzoru wad wrodzonych:78

  • Podstawowy Program Danych o Wadach Wrodzonych (BDMP) – szacowana częstość występowania FAS w latach 1979-1993 wynosiła 0,22 na 100079
  • Metropolitalny Program Wad Wrodzonych w Atlancie (MACDP) – populacyjny rejestr identyfikujący dzieci z wadami wrodzonymi w okresie noworodkowym i niemowlęcym80

System Oceny Ryzyka Ciąży (PRAMS) to sponsorowany przez CDC, trwający, oparty na populacji system nadzoru zaprojektowany do monitorowania samodzielnie zgłaszanych zachowań matczynych (w tym spożycia alkoholu), które występują przed, w trakcie i po ciąży.81

W stanie Waszyngton Sieć Diagnostyki i Zapobiegania FAS (FAS DPN) śledzi roczne rozpowszechnienie FAS według kohorty urodzeniowej wśród wszystkich dzieci zapisanych do Programu Przesiewowego FAS w ramach Programu Paszportu dla Opieki Zastępczej. Ta działalność nadzorcza niedawno udokumentowała statystycznie istotny spadek częstości występowania FAS wśród dzieci urodzonych w latach 1993-1998.82

W Australii nadzór nad FASD prowadzony jest przez Australijską Jednostkę Nadzoru Pediatrycznego oraz Australijski Rejestr FASD.83 W Kanadzie Agencja Zdrowia Publicznego Kanady, we współpracy z kluczowymi interesariuszami, prowadzi nadzór i monitorowanie w celu budowania krajowych danych nadzoru nad FASD.84

Ulepszenia w nadzorze

Ostatnie wysiłki mające na celu poprawę identyfikacji i zarządzania FASD obejmują:85

  • Badania w grupach niezbędnych w klinikach86
  • Badania populacji szkolnych87
  • Międzynarodowe badania analizujące populacje wysokiego ryzyka88
  • Zaawansowane obrazowanie 3D cech twarzy89
  • Nowe narzędzia do badań przesiewowych neurobehawioralnych90

Raport CDC z 1997 roku przedstawia metodę nadzoru nad FAS z wielu źródeł, która jest bardziej kompletna niż poprzednie metody i umożliwia porównanie wskaźników między stanami.91 Zalety korzystania z istniejących wielu źródeł danych do obliczania częstości występowania FAS to wykonalność metody i pełniejsze znajdowanie przypadków.92

Istnieje pilna potrzeba szerszych szacunków rozpowszechnienia FASD w populacji w Wielkiej Brytanii, z wykorzystaniem badań aktywnego ustalania przypadków.93 Konieczny jest również nadzór krajowy nad FASD w Kanadzie, aby lepiej zrozumieć częstość występowania tego schorzenia.9495

Wydajne systemy nadzoru oparte na populacji muszą zostać opracowane, aby dostarczyć informacji na temat pełnego wpływu prenatalnej ekspozycji na alkohol, dostarczyć informacji do działania i zbudować wolę publiczną i wsparcie niezbędne do zapobiegania FASD.96

Potrzeba standaryzacji metod nadzoru

Epidemiologia i nadzór nad FAS, związanymi z alkoholem wadami wrodzonymi (ARBD) i związanymi z alkoholem zaburzeniami rozwoju neurologicznego (ARND) są ciągłe, ale obecnie utrudnione przez niespójne metody i kryteria gromadzenia odpowiednich danych.97

Literatura na temat epidemiologii FAS i ARBD lub ARND jest obszerna i skomplikowana przez różnice w definicji wyników w tej rozwijającej się dziedzinie.98 Szacunki epidemiologiczne FASD są często niejednorodne i niedoszacowane.99

Nadzór zdrowia publicznego nad dziećmi z FASD jest priorytetem dla CDC, ale podobnie jak nie ma standardowej definicji badawczej FASD, nie ma również standardowej definicji przypadku nadzoru.100 Rozbieżności w kryteriach stanowią zagrożenie dla ważności diagnoz FASD w odniesieniu do niedokładnych szacunków częstości występowania i rozpowszechnienia.101

Porównanie wskaźników rozpowszechnienia FASD w różnych regionach świata
Region FAS (na 1000) FASD (na 1000) Metoda badawcza
Globalnie 0,15-1,5 7,7 Metaanaliza
Region Europejski WHO 19,8 Badania populacyjne
Stany Zjednoczone 0,2-1,5 10-50 Badania szkolne i rejestry medyczne
Kanada 1,0 (diagnozowane) Badanie zdrowia dzieci i młodzieży
Wielka Brytania 60-170 Badania przesiewowe
Południowa Afryka 111,1 Badania populacyjne
Chorwacja 53,3 Badania populacyjne
Irlandia 47,5 Badania populacyjne
Region wschodniego basenu Morza Śródziemnego WHO 0,1 Badania populacyjne

Znaczenie wczesnej diagnozy i interwencji

Wczesna diagnoza FASD ma kluczowe znaczenie dla zapewnienia odpowiedniego wsparcia osobom dotkniętym tym zaburzeniem i może prowadzić do lepszych wyników długoterminowych. Zrozumienie znaczenia wczesnej diagnozy i interwencji jest istotne dla skutecznego zarządzania FASD.

Korzyści z wczesnej diagnozy

Diagnozowanie FASD u dzieci i dorosłych odgrywa kluczową rolę w identyfikacji współistniejących warunków, dostępie do wsparcia zawodowego, pomocy mieszkaniowej i finansowej, interwencji psychologicznych oraz specjalistycznego doradztwa prawnego.102

Wczesna interwencja jest konieczna do optymalizacji wyników zdrowotnych.103 Chociaż młody mózg jest adaptowalny, prenatalnego uszkodzenia mózgu nie można odwrócić, dlatego w przypadku FASD przyszłością musi być profilaktyka.104

Ochronny efekt wczesnej diagnozy FASD może zmniejszyć ryzyko dodatkowych niepełnosprawności i złagodzić konsekwencje na całe życie.105 Ciągła opieka w wspierającym domu pediatrycznym jest ważnym elementem osiągnięcia zdrowia i dobrostanu dla każdego dziecka z FASD i jego rodziny.106

Diagnoza może prowadzić do zmiany paradygmatu w postawie i percepcji wobec dotkniętej osoby, od trudnej osoby lub socjopaty do osoby, która jest upośledzona neurologicznie i która potrzebuje odpowiedniej pomocy w określonym zarządzaniu i leczeniu.107

Kryteria diagnostyczne

Diagnoza zespołu alkoholowego płodu i częściowego zespołu alkoholowego płodu opiera się na określonych charakterystykach klinicznych i nie wymaga potwierdzonego używania alkoholu podczas ciąży.108

Diagnoza rozpoczyna się od oceny prenatalnej ekspozycji na alkohol, w tym ilości spożywanego alkoholu, częstotliwości używania i czasu spożycia podczas ciąży.109 Kryteria diagnostyczne dla FAS lub PFAS nie wymagają potwierdzonego używania alkoholu, jeśli obecne są charakterystyczne cechy.110

Jednakże potwierdzona nieobecność ekspozycji na alkohol wyklucza diagnozy.111 Potwierdzenie ekspozycji na alkohol jest wymagane do diagnozy zaburzenia neurorozwojowego związanego z alkoholem i wad wrodzonych związanych z alkoholem.112

Leczenie i interwencje

Nie ma lekarstwa na FASD.113 Leczenie polega na zapewnieniu medycznego domu dla pacjenta i rodziny, zarządzaniu współistniejącymi schorzeniami, zapewnieniu wsparcia żywieniowego, rozwiązywaniu problemów behawioralnych i emocjonalnych, organizowaniu skierowań na terapie habilitacyjne, koordynowaniu opieki z zespołem multidyscyplinarnym i edukacji rodziców.114

Chociaż FASD trwa całe życie i nie ma na nie lekarstwa, badania pokazują, że usługi leczenia wczesnej interwencji mogą poprawić rozwój dziecka.115

Pewne czynniki ochronne (tj. czynniki, które mogą zmniejszyć wpływ objawów) mogą pomóc zmniejszyć niektóre skutki FASD. Czynniki te mogą pomóc osobom z FASD osiągnąć ich pełny potencjał.116

Podsumowanie

Spektrum płodowego alkoholowego zaburzenia rozwoju (FASD) stanowi poważny problem zdrowia publicznego o globalnym zasięgu, z szacowaną częstością występowania wynoszącą 0,77% na całym świecie i znacznie wyższymi wskaźnikami w Europie i Ameryce Północnej. Dokładne określenie rozpowszechnienia FASD jest wyzwaniem ze względu na trudności diagnostyczne, brak standaryzacji metod nadzoru oraz niedostateczne raportowanie przypadków.123

Późna identyfikacja, trudności w uzyskaniu dokładnej historii ekspozycji na alkohol oraz brak charakterystycznych cech fizycznych u wielu osób z FASD przyczyniają się do niedodiagnozowania tego zaburzenia.45 Najnowsze badania wskazują, że nawet do 5% dzieci w Stanach Zjednoczonych może być dotkniętych FASD, co czyni go znacznie poważniejszym problemem, niż wcześniej sądzono.67

Konsekwencje FASD są długotrwałe i mogą obejmować zaburzenia poznawcze, problemy emocjonalne i behawioralne, trudności w nauce oraz wtórne niepełnosprawności, które wpływają na jakość życia i funkcjonowanie społeczne.89

Skuteczny nadzór nad FASD wymaga wieloźródłowego podejścia, które może lepiej identyfikować przypadki i zapewnić bardziej dokładne szacunki rozpowszechnienia.10 Nadzór jest konieczny do monitorowania wzorców FASD i wpływu działań profilaktycznych.11

Zapobieganie FASD pozostaje najważniejszym celem zdrowia publicznego, ponieważ jest to w pełni możliwe do uniknięcia zaburzenie. Edukacja, badania przesiewowe i interwencje dla kobiet w wieku rozrodczym, a także zwiększanie świadomości na temat ryzyka związanego ze spożywaniem alkoholu podczas ciąży, są kluczowymi strategiami zapobiegania FASD.1213

Wczesna diagnoza i kompleksowe podejście do leczenia mogą złagodzić niektóre negatywne skutki FASD i poprawić długoterminowe wyniki dla dotkniętych osób.1415 Przyszłe działania powinny się koncentrować na rozwoju skuteczniejszych metod nadzoru, standaryzacji kryteriów diagnostycznych oraz zwiększaniu dostępu do usług dla osób z FASD i ich rodzin.16

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 11.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Diagnosis, epidemiology, assessment, pathophysiology, and management of fetal alcohol spectrum disorders
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6995665/
    Prenatal alcohol exposure (PAE) frequently causes neurodevelopmental disorder, yet fetal alcohol spectrum disorders (FASD) are often undiagnosed. Global prevalence rates of 0.77% for FASD and European / North American rates of 25% highlight the need for neurologists to engage in identification, assessment, and treatment of this preventable disorder. […] FASD results from PAE and affects 0.77% of the global population and 20-50% in Europe and North America, with variation by country and epidemiological method. […] The high public health burden of FASD includes lifelong physical and cognitive disability, behavioral disturbance, psychiatric and medical comorbidity, diminished productivity, unemployment, homelessness, and incarceration. […] Recent efforts to improve identification and management of FASD include studies in non-clinically-referred groups, studies of school-based populations, international studies examining high risk populations, advanced 3D imaging of facial characteristics, and new neurobehavioral screening tools.
  • #2 Fetal alcohol spectrum disorder – Wikipedia
    https://en.wikipedia.org/wiki/Fetal_alcohol_spectrum_disorder
    Fetal alcohol spectrum disorders (FASDs) are a group of conditions that can occur in a person who is exposed to alcohol during gestation. FASD affects 1 in 20 Americans, but is highly misdiagnosed and underdiagnosed. […] The risk of FASD increases with the amount consumed, the frequency of consumption, and the longer duration of alcohol consumption during pregnancy, particularly binge drinking. […] Diagnosis is based on an assessment of growth, facial features, central nervous system, and alcohol exposure by a multidisciplinary team of professionals. […] Almost all experts recommend that the mother abstain from alcohol use during pregnancy to prevent FASDs. […] Globally, one in 10 women drinks alcohol during pregnancy, and the prevalence of having any FASD disorder is estimated to be at least 1 in 20.
  • #2 Diagnosis, epidemiology, assessment, pathophysiology, and management of fetal alcohol spectrum disorders
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6995665/
    The global prevalence rates of Fetal Alcohol Syndrome (FAS) and the full spectrum of PAE-related conditions were estimated in a meta-analysis to be 0.15% and 0.77%, respectively. […] High FASD prevalence reflects the high prevalence of alcohol use and PAE: approximately 25% of 18-34 year old men and women binge drink, and 73% of pregnancies are alcohol-exposed. […] FASD is a preventable condition that can be addressed through public health efforts, including supporting timely abstinence from alcohol, alcohol abuse prevention, addiction treatment, and birth control. […] The public health impact of FASD is amplified by significant neuropsychiatric and medical co-occurring / co-morbid conditions. […] Studies of individuals clinically diagnosed with FASD have some inherent bias, because treatment-seeking individuals have more medical, cognitive, and behavioral problems than non-treatment seeking individuals.
  • #3 Assessment of Fetal Alcohol Spectrum Disorders
    https://iris.paho.org/handle/10665.2/52216
    Fetal alcohol spectrum disorders (FASD) represent a range of physical, mental, and behavioral disabilities caused by alcohol use during pregnancy, or prenatal alcohol exposure (PAE). FASDs are considered to be one of the leading preventable causes of developmental disability. […] Despite its high prevalence, FASD is often misdiagnosed or underdiagnosed, making interventions more challenging or delayed. Earlier diagnosis yields greater benefits for affected children, which include a reduction in secondary disabilities such as substance use disorders and learning and cognitive disabilities leading to school failure, and improved life outcomes. […] Most importantly, diagnosis provides a context for understanding a child’s behavior. When the environment surrounding a child with an FASD opts to focus on the child’s strengths as a means for intervention, there is a greater likelihood of that child achieving success as an adult. Diagnosis of FASD is further beneficial to the extent that it leads to a reduction of future births of children with FASD.
  • #3 Fetal alcohol spectrum disorder – Wikipedia
    https://en.wikipedia.org/wiki/Fetal_alcohol_spectrum_disorder
    Fetal alcohol spectrum disorders (FASDs) are a group of conditions that can occur in a person who is exposed to alcohol during gestation. FASD affects 1 in 20 Americans, but is highly misdiagnosed and underdiagnosed. […] The risk of FASD increases with the amount consumed, the frequency of consumption, and the longer duration of alcohol consumption during pregnancy, particularly binge drinking. […] Diagnosis is based on an assessment of growth, facial features, central nervous system, and alcohol exposure by a multidisciplinary team of professionals. […] Almost all experts recommend that the mother abstain from alcohol use during pregnancy to prevent FASDs. […] Globally, one in 10 women drinks alcohol during pregnancy, and the prevalence of having any FASD disorder is estimated to be at least 1 in 20.
  • #3 Diagnosis, epidemiology, assessment, pathophysiology, and management of fetal alcohol spectrum disorders
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6995665/
    Diagnosing FASD in children and adults plays a critical role in identifying co-morbid and co-occurring conditions and accessing vocational support, housing and financial assistance, psychological interventions, and specialized legal counseling. […] FASD represents a global public health problem that remains under-recognized and under-diagnosed despite its high prevalence and cost to society.
  • #4 Fetal Alcohol Spectrum Disorder | Intellectual Disability and Health
    https://www.intellectualdisability.info/conditions-associated-with-intellectual-disability/articles/fetal-alcohol-spectrum-disorder
    Fetal alcohol spectrum disorders is an umbrella term for a set of disorders caused by the consumption of alcohol by a mother whilst pregnant. […] O’Leary recently summarised the epidemiological research into fetal alcohol spectrum disorders concluding that the estimated worldwide prevalence is around 1 per 100 for fetal alcohol spectrum disorders, making it the most common cause of intellectual difficulties. […] Knowledge levels about fetal alcohol spectrum disorders by the general public and health professionals in the UK are not accurately known. […] The estimated extra cost of fetal alcohol spectrum disorders in USA in has been estimated at $500,000 per individual over a 20 year period. […] For a condition that can be prevented, increasing awareness, education and UK based research will help to allow access to local provisions and could be expected to reduce the prevalence of the condition as well as the human cost in the future.
  • #4 Italian Guidelines for the diagnosis and treatment of Fetal Alcohol Spectrum Disorders: epidemiology | Rivista di Psichiatria
    https://www.rivistadipsichiatria.it/archivio/4360/articoli/43516/
    Fetal Alcohol Spectrum Disorders (FASD) are a prevalent issue worldwide. Prevalence estimates are crucial for various reasons, including setting public health policy priorities, securing funding for public health initiatives, planning healthcare strategies, allocating resources for healthcare and prevention, and planning and delivering healthcare to high-needs populations. Diagnosing the epidemiological aspects of FASD and alcohol consumption during pregnancy is a challenge due to the difficulties of accurate diagnosis. It is crucial to acknowledge that the data currently available on FASD may not always reflect precisely the actual epidemiological situation due to various methodological and behavioral concerns in the studies. […] The estimated global prevalence of FASD is 7.7 cases per 1,000 individuals. FASD prevalence is highest in the WHO European Region (19.8 per 1,000) and lowest in the WHO Eastern Mediterranean Region (0.1 per 1,000), which is consistent with rates of alcohol use during pregnancy.
  • #4 Fetal alcohol spectrum disorders: Neurobehavioral profiles | Encyclopedia on Early Childhood Development
    https://www.child-encyclopedia.com/fetal-alcohol-spectrum-disorders-fasd/according-experts/neurobehavioural-profiles-individuals-fetal
    Prenatal exposure to alcohol is the leading preventable cause of birth defects, developmental disorders, and intellectual disabilities in children. The prevalence of fetal alcohol spectrum disorders (FASD) is estimated to range between 1.1 and 5.0% in the United States, and has been identified in all racial and ethnic groups. […] The identification of children with heavy prenatal alcohol exposure is impeded by the fact that along the continuum of FASD, only diagnoses on the severe end of the spectrum (i.e. FAS and partial FAS) are characterized by physical facial features. The majority of alcohol-affected children lack some or all of these physical markers and are therefore more difficult to identify, especially if a clear history of alcohol exposure is unavailable. Despite the presence of significant neurobehavioural impairments, many children are missed (80.1%) or misdiagnosed (6.4%).
  • #5 Fetal Alcohol Spectrum Disorders and Inadequacy of Care: Importance of Raising Awareness in Clinical Practice
    https://www.mdpi.com/2227-9067/11/1/5
    Prenatal alcohol exposure is one of the major avoidable causes of developmental disruption and health abnormalities in children. Fetal alcohol spectrum disorders (FASDs), a significant consequence of prenatal alcohol exposure, have gained more attention recently. […] Research shows the prevalence of FASDs in 76 countries is > 1% and is high in individuals living in out-of-home care or engaged in justice and mental health systems. […] High rates of alcohol consumption during pregnancy allow us to suspect a high prevalence of fetal alcohol spectrum disorders. The global prevalence of FASDs in children and youth in the general population is 7.7 per 1000 people. The highest prevalence ratio is in the European Region (19.8 per 1000 people). […] Despite many public education programs regarding alcohol consumption during pregnancy, the percentage of pregnant women consuming alcohol is increasing. According to data from the Centers for Disease Control and Prevention, alcohol consumption in pregnant women increased from 7.6% in 2012 to 10.2% in 2015.
  • #5 Fetal alcohol spectrum disorder: prevention, identification and support need more resources | PolicyBristol | University of Bristol
    https://www.bristol.ac.uk/policybristol/policy-briefings/fasd-uk-prevalence/
    Up to 17 per cent of UK children could have symptoms consistent with fetal alcohol spectrum disorder (FASD). […] FASD is considered a hidden disability because most individuals with it do not show physical features. […] The UK has the fourth highest level of prenatal alcohol use in the world, yet rates of FASD are unknown. […] Before this study no estimates existed on how many people in the UK may have FASD. […] FASD is likely to remain a significant public health concern in the UK. […] A current UK prevalence study is urgently needed. […] Up to date data is needed for government and service commissioners to plan for and provide appropriate levels of service. […] This study reveals a mismatch between likely prevalence and clinical expectation that FASD is a rare condition. […] Diagnostic capacity must be increased, as people with FASD can benefit from existing specialist services.
  • #6 Fetal alcohol spectrum disorder – Wikipedia
    https://en.wikipedia.org/wiki/Fetal_alcohol_spectrum_disorder
    The rates of alcohol use, FAS, and FASD are likely to be underestimated because of the difficulty in making the diagnosis and the reluctance of clinicians to label children and mothers. […] In a recent count, the prevalence of having any FASD disorder was 1 person out of 20, but some people estimate it could be as high as 1 in 7. […] The rates of FAS and FASD are likely to be underestimated, because of the difficulty in making the diagnosis and the reluctance of clinicians to label children and mothers. […] In the United States, alcohol use at some point during pregnancy is common and appears to be rising in prevalence. […] FASD is estimated to affect between 1-2% and 5% of people in the United States and Western Europe. […] FAS is believed to occur in between 0.2 and 9 per 1,000 live births in the United States.
  • #6 The Public Health Considerations of Fetal Alcohol Spectrum Disorders | National Alcohol Beverage Control Association
    https://www.nabca.org/public-health-considerations-of-fetal-alcohol-spectrum-disorders
    Alcohol use during pregnancy is a major public health problem with 1 in 10 pregnant women reporting alcohol use in the past 30 days and 1 in 5 report binge drinking (defined as four or more drinks on at least one occasion in the past 30 days). Consuming alcohol while pregnant can lead to physical and mental problems known as Fetal Alcohol Spectrum Disorders (FASD) for a developing baby. […] The prevalence of FASD in the United States is similar to the rates found in other parts of the world where studies have been conducted. Data suggests FASD in the United States is more common than originally thought, and these conditions are underreported or underdiagnosed. […] More recently, a 2018 study featured in the Journal of the American Medical Association found a significant number of children in the U.S. have FASD, representing a more accurate prevalence estimate than prior research. Researchers collected data from over 6,000 children in four geographic regions of the United States from 2010-2016 and found that up to five percent of American children may have FASD. The study was the first school-based assessment, a method considered to be the gold standard for public health surveillance. […] National and state programs that support millions of Americans dealing with this preventable cause of birth defects are critical partners in the advancement of research, education, and advocacy efforts for the prevention, detection, and treatment of FASD.
  • #7 Fetal Alcohol Syndrome: Background, Pathophysiology, Etiology
    https://emedicine.medscape.com/article/974016-overview
    Although careful comprehensive studies have not been performed and though passive surveillance systems are inadequate to measure the incidence of fetal alcohol syndrome (FAS) or fetal alcohol spectrum disorder (FASD), the incidence of FAS in the United States is estimated to be 6-9 cases per 1000 live births; the incidence of FASD is estimated to range from 24 to 48 cases per 1000. […] The incidence is related to the population studied, with highest incidence reported in areas where heavy drinking during pregnancy is common and where attention to diagnosis is greatest. […] To date, no comprehensive population-based study with careful and standardized diagnostic methods applied to a large, representative sample of children has been performed. […] Likewise, the incidence of the broad spectrum of fetal alcohol spectrum disorder has not been well studied.
  • #7 Fetal alcohol spectrum disorders prevention and clinical guidelines research – workshop report | BMC Proceedings | Full Text
    https://bmcproc.biomedcentral.com/articles/10.1186/s12919-024-00298-x
    It is estimated that up to 1 in 20 people in the United States may have a fetal alcohol spectrum disorder (FASD), or the array of physical, cognitive, emotional, and social disorders caused by exposure to alcohol during prenatal development (May et al., JAMA 319:47482, 2018). […] The FASD Prevention and Clinical Guidelines Research initiative supports investigations of the impact of FASD on families, working-age parents, and prospective parents in the military community. […] The overarching goal of the population health assessment is to understand the prevalence burden of alcohol use and disorders prior to and during pregnancy, prenatal alcohol exposure, and FASD-related diagnoses. […] A conservative estimate of the FASD prevalence rate in the United States is 3 to 10%, with the mean at 6.5%.
  • #8 Fetal Alcohol Syndrome: Background, Pathophysiology, Etiology
    https://emedicine.medscape.com/article/974016-overview
    However, it is estimated that 2% to 5% of schoolchildren in the United States have alcohol-related effects. […] Among the subset of high-risk pregnant drinkers, estimated incidences of fetal alcohol syndrome differ because of variable definitions of heavy drinking and inconsistent methods of diagnosis. […] Therefore, rates range from 4% to as much as 44%. […] Estimated rates of fetal alcohol syndrome in international settings are sparse in the literature. […] They are based on variable definitions and methods of ascertainment and range from 1 in 1000 to less than 1 in 10,000 live births. […] In some extremely high-risk areas, such as South Africa, Croatia, and Ireland, rates of fetal alcohol spectrum disorders are estimated at 111.1, 53.3, and 47.5 cases per 1000, respectively. […] Regardless of race or ethnicity, fetal alcohol syndrome and fetal alcohol spectrum disorder occur in women who drink heavily during pregnancy. […] Rates of fetal alcohol syndrome appear to be highest among groups of low socioeconomic status.
  • #8 ClinMed International Library | Investigating Alcohol Consumption during Pregnancy for the Prevention of Fetal Alcohol Spectrum Disorders (FASD) | Obstetrics and Gynaecology Cases – Reviews |
    https://clinmedjournals.org/articles/ogcr/obstetrics-and-gynaecology-cases-reviews-ogcr-3-076.php?jid=ogcr
    Alcohol exposure causes cognitive and behavioral impairments affecting individuals all their lifelong. […] It has been estimated that during adolescence the following secondary disabilities may occur: mental health problems (90%), trouble with the law (60%), low school proficiency and dropout (60%), inappropriate sexual behavior (49%), alcohol and drug problems (33%). […] Most of the prevalence studies were performed in the United States, mainly registry or clinic based. […] Thus far nearly 15 studies of this kind have been conducted, producing a mean FAS prevalence of 0.85 per 1,000 while information on FASD are not provided. […] In literature, more than 50 clinical studies are reported, showing a mean prevalence rate of 1.8 for FAS and of 6 per 1000 for FASD. […] A minority of studies were performed on nonclinical population, based on an active case ascertainment methodology, where researchers actively evaluate a population in the field to individuate cases.
  • #9 Data and Statistics on FASDs | Fetal Alcohol Spectrum Disorders | CDC
    https://www.cdc.gov/fasd/data/index.html
    Up to 1 in 20 U.S. school-aged children may have fetal alcohol spectrum disorders (FASDs). […] We do not know exactly how many people have fetal alcohol spectrum disorders (FASDs). […] FASDs include several diagnoses related to exposure of the baby to alcohol during pregnancy. […] Using medical and other records, CDC studies have identified about 1 infant with FAS for every 1,000 live births in certain areas of the United States. […] The most recent CDC study analyzed medical and other records and found FAS in 0.3 out of 1,000 children from 7 to 9 years of age. […] Studies using in-person assessment of school-aged children in several U.S. communities report higher estimates of FAS: 6 to 9 out of 1,000 children. […] Based on the National Institutes of Health-funded community studies using physical examinations, experts estimate that the full range of FASDs in the United States and some Western European countries might number as high as 1 to 5 per 100 school-aged children (or 1% to 5% of the population).
  • #9 Fetal alcohol spectrum disorders: Neurobehavioral profiles | Encyclopedia on Early Childhood Development
    https://www.child-encyclopedia.com/fetal-alcohol-spectrum-disorders-fasd/according-experts/neurobehavioural-profiles-individuals-fetal
    Recent research has addressed whether children with FASD exhibit a unique neurobehavioural profile. The identification of a syndrome-specific profile would improve the diagnosis of children with FASD and inform interventions for all children affected by heavy prenatal alcohol exposure. […] FASD is associated with a number of neurobehavioural impairments including lower overall intelligence and deficits in executive functioning, learning and memory, language, visual-spatial functioning, and attention. […] Prenatal exposure to alcohol affects 1.1 to 5.0% of the population and leads to a spectrum of neurobehavioural consequences, including decreased overall intelligence and specific deficits in executive functioning, learning, memory, language, visual-spatial skills, and attention. Children with FASD display deficits in daily living skills and are at a higher risk for problem behaviours. […] The identification of a syndrome-specific profile would improve diagnosis of children with heavy prenatal exposure to alcohol, especially for the majority of children with FASD who do not display the facial dysmorphology.
  • #10 Fetal Alcohol Syndrome | Diagnosis | Epidemiology
    https://anchoredtidesrecovery.com/fetal-alcohol-syndrome-diagnosis-epidemiology-prevention-and-treatment/
    Fetal alcohol syndrome (FAS) is also known as a fetal alcohol spectrum disorder (FASDs). […] According to the Centers for Disease Control and Prevention (CDC), we dont know how many people have fetal alcohol spectrum disorders. We use varying approaches to estimate how many people in our population might be living with the condition. […] Using medical records primarily, studies from the CDC show a rate of 0.2 to 1.5 infants with FAS for every 1,000 births in the United States. […] Recently, an epidemiological study by the CDC found FAS in 0.3 out of 1,000 children between 7 and 9. […] According to studies from the National Institutes of Health using physical exams, the actual range of FASDs in the United States and some countries in Western Europe could be as high as 1 to 5 per 100 childrenaround 1% to 5% of the population. […] A study from 2020 published in the American Journal of Preventive Medicine found patterns of maternal alcohol exposure and binge drinking in pregnant women between 18 and 44 in the U.S. went up from 2011 to 2018.
  • #10
    https://beta.cdc.gov/mmwr/preview/mmwrhtml/00050021.htm
    This report presents a multiple-source method for FAS surveillance that is more complete than previous methods and that enables comparison of rates between states. […] During 1981-1989, MACDP and MADDSP combined identified 92 children with possible FAS: MACDP uniquely identified 50 (54%) of these possible cases; MADDSP uniquely identified 31 (34%); and both registries identified 11 (12%). […] The observed prevalence of full FAS was 1.0 cases per 10,000 live-born infants, and the observed prevalence of both full and partial FAS was 2.5 cases per 10,000. […] The estimated prevalence derived from capture-recapture analysis was 5.1 cases of full and partial FAS per 10,000. […] During 1981-1989, prevalence of full or full and partial FAS remained stable. […] The findings in this report indicate that, based on case confirmations conducted in 1997, the observed prevalence of full FAS among children born in Atlanta during 1981-1989 was 1.0 cases per 10,000 live-born infants and 2.5 per 10,000 for both full and partial FAS. […] The advantages of using existing multiple data sources to calculate the prevalence of FAS are the feasibility of the method and more complete casefinding. […] Surveillance is necessary to monitor patterns of FAS and the impact of prevention efforts.
  • #11 Data and Statistics on FASDs | Fetal Alcohol Spectrum Disorders | CDC
    https://www.cdc.gov/fasd/data/index.html
    Up to 1 in 20 U.S. school-aged children may have fetal alcohol spectrum disorders (FASDs). […] We do not know exactly how many people have fetal alcohol spectrum disorders (FASDs). […] FASDs include several diagnoses related to exposure of the baby to alcohol during pregnancy. […] Using medical and other records, CDC studies have identified about 1 infant with FAS for every 1,000 live births in certain areas of the United States. […] The most recent CDC study analyzed medical and other records and found FAS in 0.3 out of 1,000 children from 7 to 9 years of age. […] Studies using in-person assessment of school-aged children in several U.S. communities report higher estimates of FAS: 6 to 9 out of 1,000 children. […] Based on the National Institutes of Health-funded community studies using physical examinations, experts estimate that the full range of FASDs in the United States and some Western European countries might number as high as 1 to 5 per 100 school-aged children (or 1% to 5% of the population).
  • #11
    https://beta.cdc.gov/mmwr/preview/mmwrhtml/00050021.htm
    This report presents a multiple-source method for FAS surveillance that is more complete than previous methods and that enables comparison of rates between states. […] During 1981-1989, MACDP and MADDSP combined identified 92 children with possible FAS: MACDP uniquely identified 50 (54%) of these possible cases; MADDSP uniquely identified 31 (34%); and both registries identified 11 (12%). […] The observed prevalence of full FAS was 1.0 cases per 10,000 live-born infants, and the observed prevalence of both full and partial FAS was 2.5 cases per 10,000. […] The estimated prevalence derived from capture-recapture analysis was 5.1 cases of full and partial FAS per 10,000. […] During 1981-1989, prevalence of full or full and partial FAS remained stable. […] The findings in this report indicate that, based on case confirmations conducted in 1997, the observed prevalence of full FAS among children born in Atlanta during 1981-1989 was 1.0 cases per 10,000 live-born infants and 2.5 per 10,000 for both full and partial FAS. […] The advantages of using existing multiple data sources to calculate the prevalence of FAS are the feasibility of the method and more complete casefinding. […] Surveillance is necessary to monitor patterns of FAS and the impact of prevention efforts.
  • #12 Data and Statistics on FASDs | Fetal Alcohol Spectrum Disorders | CDC
    https://www.cdc.gov/fasd/data/index.html
    Up to 1 in 20 U.S. school-aged children may have fetal alcohol spectrum disorders (FASDs). […] We do not know exactly how many people have fetal alcohol spectrum disorders (FASDs). […] FASDs include several diagnoses related to exposure of the baby to alcohol during pregnancy. […] Using medical and other records, CDC studies have identified about 1 infant with FAS for every 1,000 live births in certain areas of the United States. […] The most recent CDC study analyzed medical and other records and found FAS in 0.3 out of 1,000 children from 7 to 9 years of age. […] Studies using in-person assessment of school-aged children in several U.S. communities report higher estimates of FAS: 6 to 9 out of 1,000 children. […] Based on the National Institutes of Health-funded community studies using physical examinations, experts estimate that the full range of FASDs in the United States and some Western European countries might number as high as 1 to 5 per 100 school-aged children (or 1% to 5% of the population).
  • #12 ClinMed International Library | Investigating Alcohol Consumption during Pregnancy for the Prevention of Fetal Alcohol Spectrum Disorders (FASD) | Obstetrics and Gynaecology Cases – Reviews |
    https://clinmedjournals.org/articles/ogcr/obstetrics-and-gynaecology-cases-reviews-ogcr-3-076.php?jid=ogcr
    Professionals’ recommendations and early identification of at-risk women are crucial, as fetal alcohol effects are 100% preventable just suspending consumption during pre-conception time and pregnancy. […] Even if differences may exist in the main description of the syndrome, the following features are commonly recognized in children prenatally exposed to alcohol: specific facial anomalies, growth delay, central nervous system (CNS) problems and intellectual disabilities and behavioral problems. […] The IOM describes the following revised diagnostic criteria: A full syndrome (FAS) that includes, at least, two of the above-mentioned facial features; growth deficiencies and CNS problems, including structural brain anomalies or head circumference equal or below the tenth percentile. […] The term FASD has recently been introduced as a nondiagnostic term to comprehend the whole range of possible alcohol-related damage in children exposed, including also effects like abortion.
  • #13 Fetal Alcohol Spectrum Disorders
    https://www.aap.org/en/patient-care/fetal-alcohol-spectrum-disorders/?srsltid=AfmBOor4nxTA-p7M92c-WYlmwxmNIzx6izEsM5Sf24WndXIZv5HGAVhd
    Fetal Alcohol Spectrum Disorder is an umbrella term describing a broad range of adverse developmental effects that can occur in an individual with prenatal exposure to alcohol. […] It is not known how many people in the United States have an FASD. Several initial studies, using active case findings of school-aged children, indicate that 1% to 5% of children in the United States may have an FASD. […] Centers for Disease Control and Prevention data indicate that approximately 12% of pregnancies may have alcohol exposure, which can lead to FASD birth defects. […] The protective effect of early FASD diagnosis can reduce the risk of additional disabilities and mitigate lifelong consequences. […] Ongoing care in a supportive pediatric home is an important component to achieving health and wellbeing for any child with an FASD and their family.
  • #13 ClinMed International Library | Investigating Alcohol Consumption during Pregnancy for the Prevention of Fetal Alcohol Spectrum Disorders (FASD) | Obstetrics and Gynaecology Cases – Reviews |
    https://clinmedjournals.org/articles/ogcr/obstetrics-and-gynaecology-cases-reviews-ogcr-3-076.php?jid=ogcr
    Prevalence of women drinking during pregnancy in the US decreased over the last decade, from 20% prior to 2001 to 10.2% in 2011-2013 while in Europe rates range from 25% in Spain to 79% in the United Kingdom and Ireland. […] Thus, the identification of women still drinking during pregnancy has main implications for prevention. […] Early detection of alcohol consumption during pregnancy is essential both for its preventive and therapeutic implications. […] The burden of lifelong disabilities caused by alcohol exposure during pregnancy is extreme at individual, familial and societal level. […] Public agencies all over the world underline the crucial importance of prevention through the enactment of laws on labeling alcoholic beverages and the release of health statements recommending total abstinence from alcohol during pregnancy and lactation as the unique way of prevention.
  • #14 The Public Health Considerations of Fetal Alcohol Spectrum Disorders | National Alcohol Beverage Control Association
    https://www.nabca.org/public-health-considerations-of-fetal-alcohol-spectrum-disorders
    Alcohol use during pregnancy is a major public health problem with 1 in 10 pregnant women reporting alcohol use in the past 30 days and 1 in 5 report binge drinking (defined as four or more drinks on at least one occasion in the past 30 days). Consuming alcohol while pregnant can lead to physical and mental problems known as Fetal Alcohol Spectrum Disorders (FASD) for a developing baby. […] The prevalence of FASD in the United States is similar to the rates found in other parts of the world where studies have been conducted. Data suggests FASD in the United States is more common than originally thought, and these conditions are underreported or underdiagnosed. […] More recently, a 2018 study featured in the Journal of the American Medical Association found a significant number of children in the U.S. have FASD, representing a more accurate prevalence estimate than prior research. Researchers collected data from over 6,000 children in four geographic regions of the United States from 2010-2016 and found that up to five percent of American children may have FASD. The study was the first school-based assessment, a method considered to be the gold standard for public health surveillance. […] National and state programs that support millions of Americans dealing with this preventable cause of birth defects are critical partners in the advancement of research, education, and advocacy efforts for the prevention, detection, and treatment of FASD.
  • #14 Data and Statistics on FASDs | Fetal Alcohol Spectrum Disorders | CDC
    https://www.cdc.gov/fasd/data/index.html
    FASDs are a group of diagnoses that can occur in a person who was exposed to alcohol before birth. […] The lifetime cost of care for one individual with FAS in 2002 was estimated to be $2 million. […] It is estimated that the cost to the United States for FAS alone is over $4 billion annually. […] People with fetal alcohol spectrum disorders (FASDs) can experience lifelong issues. […] FASDs last a lifetime. […] There is no cure for FASDs, but research shows that early intervention treatment services can improve a child’s development.
  • #15 Fetal alcohol spectrum disorders prevention and clinical guidelines research – workshop report | BMC Proceedings | Full Text
    https://bmcproc.biomedcentral.com/articles/10.1186/s12919-024-00298-x
    It is estimated that up to 1 in 20 people in the United States may have a fetal alcohol spectrum disorder (FASD), or the array of physical, cognitive, emotional, and social disorders caused by exposure to alcohol during prenatal development (May et al., JAMA 319:47482, 2018). […] The FASD Prevention and Clinical Guidelines Research initiative supports investigations of the impact of FASD on families, working-age parents, and prospective parents in the military community. […] The overarching goal of the population health assessment is to understand the prevalence burden of alcohol use and disorders prior to and during pregnancy, prenatal alcohol exposure, and FASD-related diagnoses. […] A conservative estimate of the FASD prevalence rate in the United States is 3 to 10%, with the mean at 6.5%.
  • #15 What’s New
    https://www.cdph.ca.gov/Programs/CCDPHP/sapb/Pages/FASDs.aspx
    Although FASDs last a lifetime and there is no cure, studies show that treatment services in early childhood can help the child’s development. […] Certain protective factors (i.e., factors that may reduce impact of symptoms) can help reduce some of the effects of FASDs. These factors can help people with FASDs reach their full potential. […] It is important to get help as soon as possible if you think your child may have an FASD or other developmental problem. […] It is important to stop drinking alcohol if you are pregnant or trying to become pregnant. If you are having a hard time not drinking alcohol, you are not alone and help is available. […] It’s never too late to stop alcohol use during pregnancy and it’s important to ask for help.
  • #16
    https://beta.cdc.gov/mmwr/preview/mmwrhtml/00050021.htm
    This report presents a multiple-source method for FAS surveillance that is more complete than previous methods and that enables comparison of rates between states. […] During 1981-1989, MACDP and MADDSP combined identified 92 children with possible FAS: MACDP uniquely identified 50 (54%) of these possible cases; MADDSP uniquely identified 31 (34%); and both registries identified 11 (12%). […] The observed prevalence of full FAS was 1.0 cases per 10,000 live-born infants, and the observed prevalence of both full and partial FAS was 2.5 cases per 10,000. […] The estimated prevalence derived from capture-recapture analysis was 5.1 cases of full and partial FAS per 10,000. […] During 1981-1989, prevalence of full or full and partial FAS remained stable. […] The findings in this report indicate that, based on case confirmations conducted in 1997, the observed prevalence of full FAS among children born in Atlanta during 1981-1989 was 1.0 cases per 10,000 live-born infants and 2.5 per 10,000 for both full and partial FAS. […] The advantages of using existing multiple data sources to calculate the prevalence of FAS are the feasibility of the method and more complete casefinding. […] Surveillance is necessary to monitor patterns of FAS and the impact of prevention efforts.
  • #16 Diagnostic Issues Affecting the Epidemiology of Fetal Alcohol Spectrum Disorders | Journal of Population Therapeutics and Clinical Pharmacology
    https://jptcp.com/index.php/jptcp/article/view/596
    Epidemiological measures of the prevalence of fetal alcohol spectrum disorders (FASD) vary greatly in the literature. […] Estimates of the prevalence of FASD primarily depend on the diagnostic criteria currently available. […] To date, the Canadian guidelines represent the only guidelines that have pushed for a uniform diagnostic capacity through harmonizing the IoM and 4-Digit Diagnostic Code criteria. […] There are profound implications of relaxed and strict diagnostic approaches on FAS prevalence reporting in the literature. […] Discrepancies in the criteria pose a danger to the validity of FASD diagnoses with respect to inaccurate estimates of incidence and prevalence. […] In turn, these discrepancies risk compromising the future healthcare of affected individuals with regards to intervention, counselling and treatment.
  • #17 FASD prevalence among children and youth: results from the 2019 Canadian Health Survey on Children and Youth – Canada.ca
    https://www.canada.ca/en/public-health/services/reports-publications/health-promotion-chronic-disease-prevention-canada-research-policy-practice/vol-41-no-9-2021/fasd-prevalence-children-youth-2019.html
    The prevalence of FASD among Canadian children and youth living in private dwellings was 1 per 1000 (0.1%). […] The prevalence was significantly higher among those who identified as Indigenous and lived off reserve (1.2%). […] These findings are in keeping with FASD prevalence studies that used similar passive surveillance methods. […] We need national surveillance of FASD to better understand the prevalence of this condition. […] The lack of national FASD prevalence estimates represents an important knowledge gap in informing the public health response. […] Based on the data from the 2019 CHSCY, the estimated national prevalence of diagnosed FASD among children and youth aged 1 to 17 years is 1 per 1000 or 0.1%. […] Canadian prevalence studies of FASD have employed various methods including clinical examinations and active case ascertainment while focussing on different population groups, jurisdictions and age ranges.
  • #18 FASD prevalence among children and youth: results from the 2019 Canadian Health Survey on Children and Youth – Canada.ca
    https://www.canada.ca/en/public-health/services/reports-publications/health-promotion-chronic-disease-prevention-canada-research-policy-practice/vol-41-no-9-2021/fasd-prevalence-children-youth-2019.html
    Canadian children and youth who identified as Indigenous and who lived off reserve had a significantly higher prevalence of FASD than those who did not (1.2% versus 0.1%). […] National surveillance of FASD is needed to gain a better understanding of the estimated prevalence and provide baseline numbers against which future public health actions can be evaluated.
  • #19
    https://www.gov.uk/government/publications/fetal-alcohol-spectrum-disorder-health-needs-assessment/fetal-alcohol-spectrum-disorder-health-needs-assessment
    The first national effort to quantify FASD in the UK was published late 2018. The study found a screening prevalence range in the UK of 6% to 17%. […] A prevalence study in primary schools in Greater Manchester began in 2019, led by the University of Salford. This was the first UK active ascertainment study, which is the most reliable approach to assessing prevalence. […] There are currently no prevalence studies for FASD in the UK. […] The lack of reliable prevalence estimates for England and the UK present a significant barrier to understanding and meeting the needs of those living with the condition, their families and carers. […] There is an immediate need for wider UK population-based estimates of FASD prevalence, using active case ascertainment studies.
  • #20 Fetal alcohol spectrum disorder: prevention, identification and support need more resources | PolicyBristol | University of Bristol
    https://www.bristol.ac.uk/policybristol/policy-briefings/fasd-uk-prevalence/
    Up to 17 per cent of UK children could have symptoms consistent with fetal alcohol spectrum disorder (FASD). […] FASD is considered a hidden disability because most individuals with it do not show physical features. […] The UK has the fourth highest level of prenatal alcohol use in the world, yet rates of FASD are unknown. […] Before this study no estimates existed on how many people in the UK may have FASD. […] FASD is likely to remain a significant public health concern in the UK. […] A current UK prevalence study is urgently needed. […] Up to date data is needed for government and service commissioners to plan for and provide appropriate levels of service. […] This study reveals a mismatch between likely prevalence and clinical expectation that FASD is a rare condition. […] Diagnostic capacity must be increased, as people with FASD can benefit from existing specialist services.
  • #21
    https://www.gov.uk/government/publications/fetal-alcohol-spectrum-disorder-health-needs-assessment/fetal-alcohol-spectrum-disorder-health-needs-assessment
    The first national effort to quantify FASD in the UK was published late 2018. The study found a screening prevalence range in the UK of 6% to 17%. […] A prevalence study in primary schools in Greater Manchester began in 2019, led by the University of Salford. This was the first UK active ascertainment study, which is the most reliable approach to assessing prevalence. […] There are currently no prevalence studies for FASD in the UK. […] The lack of reliable prevalence estimates for England and the UK present a significant barrier to understanding and meeting the needs of those living with the condition, their families and carers. […] There is an immediate need for wider UK population-based estimates of FASD prevalence, using active case ascertainment studies.
  • #22 IJPDS International Journal of Population Data Science
    https://ijpds.org/article/view/1703
    National FASD surveillance: Australian Paediatric Surveillance Unit and FASD Registry. […] Earlier research by CRE members indicated that Australian clinicians were unskilled or unwilling to make a FASD diagnosis and did not know where to refer for assessment or FASD management, leading government to fund diagnostic guidelines. […] Funding was also provided for national prospective surveillance of FASD through the Australian Paediatric Surveillance Unit and development of the FASD Australian Registry.
  • #23 Fetal alcohol spectrum disorders prevention and clinical guidelines research – workshop report | BMC Proceedings | Full Text
    https://bmcproc.biomedcentral.com/articles/10.1186/s12919-024-00298-x
    The most influential known risk factor is prenatal alcohol exposure. […] Maternal risk factors for FASD encompass a woman’s general physical and mental health; the type, quantity, frequency, and gestational timing of alcohol use; and social norms and practices. […] Public health surveillance of children with FASD is a priority for the CDC, but just as there is no standard research definition for FASD, there is also no standard surveillance case definition. […] The environmental scan revealed that there are clinical practice guidelines, policies, and interventions to screen for and address alcohol and substance use and disorder in pregnancy and pre-pregnancy, which are largely aligned with national recommendations. […] However, the researchers found that despite these resources, unhealthy alcohol use continues. […] Notably, researchers found that there are no FASD-specific resources. […] Together, findings point to a need for FASD-specific screening, support, and services, along with programs to raise awareness of and change the messaging and culture around alcohol use in the military.
  • #24 Fetal alcohol spectrum disorder – Wikipedia
    https://en.wikipedia.org/wiki/Fetal_alcohol_spectrum_disorder
    Fetal alcohol spectrum disorders (FASDs) are a group of conditions that can occur in a person who is exposed to alcohol during gestation. FASD affects 1 in 20 Americans, but is highly misdiagnosed and underdiagnosed. […] The risk of FASD increases with the amount consumed, the frequency of consumption, and the longer duration of alcohol consumption during pregnancy, particularly binge drinking. […] Diagnosis is based on an assessment of growth, facial features, central nervous system, and alcohol exposure by a multidisciplinary team of professionals. […] Almost all experts recommend that the mother abstain from alcohol use during pregnancy to prevent FASDs. […] Globally, one in 10 women drinks alcohol during pregnancy, and the prevalence of having any FASD disorder is estimated to be at least 1 in 20.
  • #25 Fetal Alcohol Syndrome and Fetal Alcohol Spectrum Disorders | AAFP
    https://www.aafp.org/pubs/afp/issues/2017/1015/p515.html
    Fetal alcohol syndrome (FAS) and fetal alcohol spectrum disorders (FASD) result from intrauterine exposure to alcohol and are the most common nonheritable causes of intellectual disability. […] The percentage of women who drink or binge drink during pregnancy has increased since 2012. […] FASD is a broader diagnosis that encompasses patients with FAS and others who are affected by prenatal alcohol exposure but do not meet the full criteria for FAS. […] The Centers for Disease Control and Prevention and other organizations recognize no safe amount of alcohol consumption during pregnancy and recommend complete abstinence from alcohol. […] According to the Centers for Disease Control and Prevention, the percentage of pregnant women who consume alcohol increased from 7.6% in 2012 to 10.2% in 2015, and the number of pregnant women reporting binge drinking (at least four alcoholic beverages at once) increased from 1.4% to 3.1%.
  • #26 Diagnosis, epidemiology, assessment, pathophysiology, and management of fetal alcohol spectrum disorders
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6995665/
    The global prevalence rates of Fetal Alcohol Syndrome (FAS) and the full spectrum of PAE-related conditions were estimated in a meta-analysis to be 0.15% and 0.77%, respectively. […] High FASD prevalence reflects the high prevalence of alcohol use and PAE: approximately 25% of 18-34 year old men and women binge drink, and 73% of pregnancies are alcohol-exposed. […] FASD is a preventable condition that can be addressed through public health efforts, including supporting timely abstinence from alcohol, alcohol abuse prevention, addiction treatment, and birth control. […] The public health impact of FASD is amplified by significant neuropsychiatric and medical co-occurring / co-morbid conditions. […] Studies of individuals clinically diagnosed with FASD have some inherent bias, because treatment-seeking individuals have more medical, cognitive, and behavioral problems than non-treatment seeking individuals.
  • #27 Fetal alcohol spectrum disorders prevention and clinical guidelines research – workshop report | BMC Proceedings | Full Text
    https://bmcproc.biomedcentral.com/articles/10.1186/s12919-024-00298-x
    The most influential known risk factor is prenatal alcohol exposure. […] Maternal risk factors for FASD encompass a woman’s general physical and mental health; the type, quantity, frequency, and gestational timing of alcohol use; and social norms and practices. […] Public health surveillance of children with FASD is a priority for the CDC, but just as there is no standard research definition for FASD, there is also no standard surveillance case definition. […] The environmental scan revealed that there are clinical practice guidelines, policies, and interventions to screen for and address alcohol and substance use and disorder in pregnancy and pre-pregnancy, which are largely aligned with national recommendations. […] However, the researchers found that despite these resources, unhealthy alcohol use continues. […] Notably, researchers found that there are no FASD-specific resources. […] Together, findings point to a need for FASD-specific screening, support, and services, along with programs to raise awareness of and change the messaging and culture around alcohol use in the military.
  • #28 ClinMed International Library | Investigating Alcohol Consumption during Pregnancy for the Prevention of Fetal Alcohol Spectrum Disorders (FASD) | Obstetrics and Gynaecology Cases – Reviews |
    https://clinmedjournals.org/articles/ogcr/obstetrics-and-gynaecology-cases-reviews-ogcr-3-076.php?jid=ogcr
    The main part of these studies has been performed in South Africa: due to low socioeconomic conditions, they showed very high percentages of FASD occurrence for the extremely poor condition of life in the areas chosen for the studies. […] It has been estimated that the full syndrome occurs in nearly 40% of heavily exposed pregnancies. […] The amount of alcohol consumed represents the most important risk factor for FASD. […] The kind of alcoholic beverage consumed should be taken into consideration as well. […] An Italian survey among 992 pregnant women identified the following risk factors for alcohol-exposed pregnancies: being younger (under 30), having an unplanned pregnancy, being unemployed, having a lower educational qualification and being single. […] The occurring of alcohol problems in the family environment also should be taken into consideration as a risk factor.
  • #29 Italian Guidelines for the diagnosis and treatment of Fetal Alcohol Spectrum Disorders: epidemiology | Rivista di Psichiatria
    https://www.rivistadipsichiatria.it/archivio/4360/articoli/43516/
    FASD prevalence can be up to 40 times higher than in the general population in specific subpopulations. A recent systematic review and meta-analysis shows this elevated prevalence in children in out-of-home care, correctional facilities, special education programs, and specialized clinical settings. […] Current methods for detecting FAS and FASD can underreport prevalence and only identify the most severe cases. It is crucial to identify cases of FAS and FASD in children actively. Without active case ascertainment, many children with FAS and FASD may go undetected, leading to a lack of proper diagnosis and care. […] The epidemiological data related to alcohol exposure in utero, including the prevalence of alcohol consumption during pregnancy and FASD, are often heterogeneous and underestimated. Detecting alcohol consumption is challenging due to social stigma and is particularly sensitive when interviewing pregnant women.
  • #30 Fetal Alcohol Syndrome and Fetal Alcohol Spectrum Disorders | AAFP
    https://www.aafp.org/pubs/afp/issues/2017/1015/p515.html
    Although there is wide variation in the estimated prevalence of FAS/FASD, FAS is thought to occur in 0.3 to 0.8 per 1,000 children in the United States and in 2.9 per 1,000 globally. […] The prevalence of FASD is estimated at 33.5 per 1,000 children in the United States and 22.8 per 1,000 globally. […] In the United States, FASD is least prevalent in Hispanic children and most prevalent in Native Americans and Alaska Natives. […] FAS is diagnosed at an average age of 48.3 months; however, it is commonly missed or misdiagnosed, preventing affected children from receiving needed services in a timely fashion. […] FASD carries a significant economic burden. […] The diagnosis of fetal alcohol syndrome and partial fetal alcohol syndrome is based on defined clinical characteristics and does not require confirmed alcohol use during pregnancy.
  • #31 5 Epidemiology and Surveillance of Fetal Alcohol Syndrome | Fetal Alcohol Syndrome: Diagnosis, Epidemiology, Prevention, and Treatment | The National Academies Press
    https://nap.nationalacademies.org/read/4991/chapter/7
    The Centers for Disease Control and Prevention monitors the rate of FAS in two birth defects surveillance programs. […] The overall rate of FAS was 2.97 per 1,000 for Native Americans, 0.6 per 1,000 for African Americans, 0.09 for Caucasians, 0.08 for Hispanics, and 0.03 for Asians. […] A subsequent CDC article on data from the BDMP estimated the overall incidence of FAS from 1979 to 1993 at 0.22 per 1,000. […] The CDC’s Metropolitan Atlanta Congenital Defects Program (MACDP) is a population-based registry that identifies children diagnosed with birth defects during the neonatal and infancy periods. […] In general, the surveillance of FAS is similar in these other systems. […] Given also that FAS is a complex diagnosis, it may go unrecognized at birth. […] Thus, registry-based estimates of FAS prevalence can be expected to be gross underestimates.
  • #32 Fetal Alcohol Syndrome: Background, Pathophysiology, Etiology
    https://emedicine.medscape.com/article/974016-overview
    However, it is estimated that 2% to 5% of schoolchildren in the United States have alcohol-related effects. […] Among the subset of high-risk pregnant drinkers, estimated incidences of fetal alcohol syndrome differ because of variable definitions of heavy drinking and inconsistent methods of diagnosis. […] Therefore, rates range from 4% to as much as 44%. […] Estimated rates of fetal alcohol syndrome in international settings are sparse in the literature. […] They are based on variable definitions and methods of ascertainment and range from 1 in 1000 to less than 1 in 10,000 live births. […] In some extremely high-risk areas, such as South Africa, Croatia, and Ireland, rates of fetal alcohol spectrum disorders are estimated at 111.1, 53.3, and 47.5 cases per 1000, respectively. […] Regardless of race or ethnicity, fetal alcohol syndrome and fetal alcohol spectrum disorder occur in women who drink heavily during pregnancy. […] Rates of fetal alcohol syndrome appear to be highest among groups of low socioeconomic status.
  • #33 Fetal alcohol spectrum disorder – Wikipedia
    https://en.wikipedia.org/wiki/Fetal_alcohol_spectrum_disorder
    Fetal alcohol spectrum disorders (FASDs) are a group of conditions that can occur in a person who is exposed to alcohol during gestation. FASD affects 1 in 20 Americans, but is highly misdiagnosed and underdiagnosed. […] The risk of FASD increases with the amount consumed, the frequency of consumption, and the longer duration of alcohol consumption during pregnancy, particularly binge drinking. […] Diagnosis is based on an assessment of growth, facial features, central nervous system, and alcohol exposure by a multidisciplinary team of professionals. […] Almost all experts recommend that the mother abstain from alcohol use during pregnancy to prevent FASDs. […] Globally, one in 10 women drinks alcohol during pregnancy, and the prevalence of having any FASD disorder is estimated to be at least 1 in 20.
  • #34 Prenatal alcohol exposure and associations with physical size, dysmorphology and neurodevelopment: a systematic review and meta-analysis | BMC Medicine | Full Text
    https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-024-03656-w
    Fetal alcohol spectrum disorder (FASD) is a significant public health concern, yet there is no internationally agreed set of diagnostic criteria or summary of underlying evidence to inform diagnostic decision-making. […] FASD is the leading cause of non-genetic developmental disability in many countries, affecting an estimated 7.7 per 1000 individuals. […] FASD is under-diagnosed globally, in part owing to the current lack of a unified diagnostic approach. […] Due to the complex and heterogeneous nature of FASD, over ten different diagnostic criteria are currently employed internationally. […] Establishing uniform diagnostic criteria is crucial for improving FASD identification and facilitating appropriate services for those affected. […] The key clinical components in diagnostic criteria are physical size (i.e. birth weight, birth length, postnatal weight and/or postnatal height); dysmorphology (i.e. characteristic facial features [small palpebral fissures, smooth philtrum and thin vermilion], other dysmorphic features and birth defects); functional neurodevelopmental outcomes (e.g. general intelligence, memory, attention, executive function); structural neurodevelopmental outcomes (e.g. head circumference, structural brain abnormalities); and neurological outcomes (e.g. seizures of unknown origin, cerebral palsy, hearing and vision impairment).
  • #35 Assessment of Fetal Alcohol Spectrum Disorders
    https://iris.paho.org/handle/10665.2/52216
    Fetal alcohol spectrum disorders (FASD) represent a range of physical, mental, and behavioral disabilities caused by alcohol use during pregnancy, or prenatal alcohol exposure (PAE). FASDs are considered to be one of the leading preventable causes of developmental disability. […] Despite its high prevalence, FASD is often misdiagnosed or underdiagnosed, making interventions more challenging or delayed. Earlier diagnosis yields greater benefits for affected children, which include a reduction in secondary disabilities such as substance use disorders and learning and cognitive disabilities leading to school failure, and improved life outcomes. […] Most importantly, diagnosis provides a context for understanding a child’s behavior. When the environment surrounding a child with an FASD opts to focus on the child’s strengths as a means for intervention, there is a greater likelihood of that child achieving success as an adult. Diagnosis of FASD is further beneficial to the extent that it leads to a reduction of future births of children with FASD.
  • #36 Fetal Alcohol Syndrome and Fetal Alcohol Spectrum Disorders | AAFP
    https://www.aafp.org/pubs/afp/issues/2017/1015/p515.html
    Although there is wide variation in the estimated prevalence of FAS/FASD, FAS is thought to occur in 0.3 to 0.8 per 1,000 children in the United States and in 2.9 per 1,000 globally. […] The prevalence of FASD is estimated at 33.5 per 1,000 children in the United States and 22.8 per 1,000 globally. […] In the United States, FASD is least prevalent in Hispanic children and most prevalent in Native Americans and Alaska Natives. […] FAS is diagnosed at an average age of 48.3 months; however, it is commonly missed or misdiagnosed, preventing affected children from receiving needed services in a timely fashion. […] FASD carries a significant economic burden. […] The diagnosis of fetal alcohol syndrome and partial fetal alcohol syndrome is based on defined clinical characteristics and does not require confirmed alcohol use during pregnancy.
  • #37 Fetal alcohol spectrum disorder: prevention, identification and support need more resources | PolicyBristol | University of Bristol
    https://www.bristol.ac.uk/policybristol/policy-briefings/fasd-uk-prevalence/
    Up to 17 per cent of UK children could have symptoms consistent with fetal alcohol spectrum disorder (FASD). […] FASD is considered a hidden disability because most individuals with it do not show physical features. […] The UK has the fourth highest level of prenatal alcohol use in the world, yet rates of FASD are unknown. […] Before this study no estimates existed on how many people in the UK may have FASD. […] FASD is likely to remain a significant public health concern in the UK. […] A current UK prevalence study is urgently needed. […] Up to date data is needed for government and service commissioners to plan for and provide appropriate levels of service. […] This study reveals a mismatch between likely prevalence and clinical expectation that FASD is a rare condition. […] Diagnostic capacity must be increased, as people with FASD can benefit from existing specialist services.
  • #38 Fetal alcohol spectrum disorders: Neurobehavioral profiles | Encyclopedia on Early Childhood Development
    https://www.child-encyclopedia.com/fetal-alcohol-spectrum-disorders-fasd/according-experts/neurobehavioural-profiles-individuals-fetal
    Prenatal exposure to alcohol is the leading preventable cause of birth defects, developmental disorders, and intellectual disabilities in children. The prevalence of fetal alcohol spectrum disorders (FASD) is estimated to range between 1.1 and 5.0% in the United States, and has been identified in all racial and ethnic groups. […] The identification of children with heavy prenatal alcohol exposure is impeded by the fact that along the continuum of FASD, only diagnoses on the severe end of the spectrum (i.e. FAS and partial FAS) are characterized by physical facial features. The majority of alcohol-affected children lack some or all of these physical markers and are therefore more difficult to identify, especially if a clear history of alcohol exposure is unavailable. Despite the presence of significant neurobehavioural impairments, many children are missed (80.1%) or misdiagnosed (6.4%).
  • #39 Italian Guidelines for the diagnosis and treatment of Fetal Alcohol Spectrum Disorders: epidemiology | Rivista di Psichiatria
    https://www.rivistadipsichiatria.it/archivio/4360/articoli/43516/
    FASD prevalence can be up to 40 times higher than in the general population in specific subpopulations. A recent systematic review and meta-analysis shows this elevated prevalence in children in out-of-home care, correctional facilities, special education programs, and specialized clinical settings. […] Current methods for detecting FAS and FASD can underreport prevalence and only identify the most severe cases. It is crucial to identify cases of FAS and FASD in children actively. Without active case ascertainment, many children with FAS and FASD may go undetected, leading to a lack of proper diagnosis and care. […] The epidemiological data related to alcohol exposure in utero, including the prevalence of alcohol consumption during pregnancy and FASD, are often heterogeneous and underestimated. Detecting alcohol consumption is challenging due to social stigma and is particularly sensitive when interviewing pregnant women.
  • #40 5 Epidemiology and Surveillance of Fetal Alcohol Syndrome | Fetal Alcohol Syndrome: Diagnosis, Epidemiology, Prevention, and Treatment | The National Academies Press
    https://nap.nationalacademies.org/read/4991/chapter/7
    The Centers for Disease Control and Prevention monitors the rate of FAS in two birth defects surveillance programs. […] The overall rate of FAS was 2.97 per 1,000 for Native Americans, 0.6 per 1,000 for African Americans, 0.09 for Caucasians, 0.08 for Hispanics, and 0.03 for Asians. […] A subsequent CDC article on data from the BDMP estimated the overall incidence of FAS from 1979 to 1993 at 0.22 per 1,000. […] The CDC’s Metropolitan Atlanta Congenital Defects Program (MACDP) is a population-based registry that identifies children diagnosed with birth defects during the neonatal and infancy periods. […] In general, the surveillance of FAS is similar in these other systems. […] Given also that FAS is a complex diagnosis, it may go unrecognized at birth. […] Thus, registry-based estimates of FAS prevalence can be expected to be gross underestimates.
  • #41 5 Epidemiology and Surveillance of Fetal Alcohol Syndrome | Fetal Alcohol Syndrome: Diagnosis, Epidemiology, Prevention, and Treatment | The National Academies Press
    https://nap.nationalacademies.org/read/4991/chapter/7
    The success of any public health program can be measured by comparing the incidence or prevalence of a particular societal problem before that program was implemented with its incidence or prevalence after implementation. […] Epidemiology and surveillance of fetal alcohol syndrome (FAS), alcohol-related birth defects (ARBD), and alcohol-related neurodevelopmental disorder (ARND) are ongoing but are currently hampered by inconsistent methods and criteria for gathering the appropriate data. […] The literature on the epidemiology of FAS and ARBD or ARND is extensive and complicated by differences in the definition of outcomes in this evolving field. […] The incidence of FAS has been estimated from data of three main types: information collected passively for another or for many purposes, such as birth defects registries; information gathered either retrospectively or prospectively from hospital or clinic-based populations, including subjects in controlled epidemiologic studies of the effects of maternal substance abuse; and population-based active case ascertainment.
  • #42 5 Epidemiology and Surveillance of Fetal Alcohol Syndrome | Fetal Alcohol Syndrome: Diagnosis, Epidemiology, Prevention, and Treatment | The National Academies Press
    https://nap.nationalacademies.org/read/4991/chapter/7
    The success of any public health program can be measured by comparing the incidence or prevalence of a particular societal problem before that program was implemented with its incidence or prevalence after implementation. […] Epidemiology and surveillance of fetal alcohol syndrome (FAS), alcohol-related birth defects (ARBD), and alcohol-related neurodevelopmental disorder (ARND) are ongoing but are currently hampered by inconsistent methods and criteria for gathering the appropriate data. […] The literature on the epidemiology of FAS and ARBD or ARND is extensive and complicated by differences in the definition of outcomes in this evolving field. […] The incidence of FAS has been estimated from data of three main types: information collected passively for another or for many purposes, such as birth defects registries; information gathered either retrospectively or prospectively from hospital or clinic-based populations, including subjects in controlled epidemiologic studies of the effects of maternal substance abuse; and population-based active case ascertainment.
  • #43 5 Epidemiology and Surveillance of Fetal Alcohol Syndrome | Fetal Alcohol Syndrome: Diagnosis, Epidemiology, Prevention, and Treatment | The National Academies Press
    https://nap.nationalacademies.org/read/4991/chapter/7
    The success of any public health program can be measured by comparing the incidence or prevalence of a particular societal problem before that program was implemented with its incidence or prevalence after implementation. […] Epidemiology and surveillance of fetal alcohol syndrome (FAS), alcohol-related birth defects (ARBD), and alcohol-related neurodevelopmental disorder (ARND) are ongoing but are currently hampered by inconsistent methods and criteria for gathering the appropriate data. […] The literature on the epidemiology of FAS and ARBD or ARND is extensive and complicated by differences in the definition of outcomes in this evolving field. […] The incidence of FAS has been estimated from data of three main types: information collected passively for another or for many purposes, such as birth defects registries; information gathered either retrospectively or prospectively from hospital or clinic-based populations, including subjects in controlled epidemiologic studies of the effects of maternal substance abuse; and population-based active case ascertainment.
  • #44 5 Epidemiology and Surveillance of Fetal Alcohol Syndrome | Fetal Alcohol Syndrome: Diagnosis, Epidemiology, Prevention, and Treatment | The National Academies Press
    https://nap.nationalacademies.org/read/4991/chapter/7
    The success of any public health program can be measured by comparing the incidence or prevalence of a particular societal problem before that program was implemented with its incidence or prevalence after implementation. […] Epidemiology and surveillance of fetal alcohol syndrome (FAS), alcohol-related birth defects (ARBD), and alcohol-related neurodevelopmental disorder (ARND) are ongoing but are currently hampered by inconsistent methods and criteria for gathering the appropriate data. […] The literature on the epidemiology of FAS and ARBD or ARND is extensive and complicated by differences in the definition of outcomes in this evolving field. […] The incidence of FAS has been estimated from data of three main types: information collected passively for another or for many purposes, such as birth defects registries; information gathered either retrospectively or prospectively from hospital or clinic-based populations, including subjects in controlled epidemiologic studies of the effects of maternal substance abuse; and population-based active case ascertainment.
  • #45 5 Epidemiology and Surveillance of Fetal Alcohol Syndrome | Fetal Alcohol Syndrome: Diagnosis, Epidemiology, Prevention, and Treatment | The National Academies Press
    https://nap.nationalacademies.org/read/4991/chapter/7
    The Centers for Disease Control and Prevention monitors the rate of FAS in two birth defects surveillance programs. […] The overall rate of FAS was 2.97 per 1,000 for Native Americans, 0.6 per 1,000 for African Americans, 0.09 for Caucasians, 0.08 for Hispanics, and 0.03 for Asians. […] A subsequent CDC article on data from the BDMP estimated the overall incidence of FAS from 1979 to 1993 at 0.22 per 1,000. […] The CDC’s Metropolitan Atlanta Congenital Defects Program (MACDP) is a population-based registry that identifies children diagnosed with birth defects during the neonatal and infancy periods. […] In general, the surveillance of FAS is similar in these other systems. […] Given also that FAS is a complex diagnosis, it may go unrecognized at birth. […] Thus, registry-based estimates of FAS prevalence can be expected to be gross underestimates.
  • #46 5 Epidemiology and Surveillance of Fetal Alcohol Syndrome | Fetal Alcohol Syndrome: Diagnosis, Epidemiology, Prevention, and Treatment | The National Academies Press
    https://nap.nationalacademies.org/read/4991/chapter/7
    Studies that have produced rates, or estimated rates, of the incidence of FAS have been carried out in a number of countries. […] In the United States, incidence rates vary widely depending on study site. […] From the clinic-based studies, one can conclude that the prevalence of FAS varies by the prevalence of the problem in the select population served by the hospital or clinic and by the methodology used for case identification and ascertainment. […] Population-based epidemiologic studies using active case ascertainment can assist in addressing some of the criticisms mentioned above, can provide relevant information on the magnitude of the problem in specific communities, and may be more useful for comprehensive community-based prevention efforts. […] The overall significance of these population-based studies is that they may provide more accurate prevalence data and could point the way to more valuable information for comprehensive prevention programs.
  • #47 5 Epidemiology and Surveillance of Fetal Alcohol Syndrome | Fetal Alcohol Syndrome: Diagnosis, Epidemiology, Prevention, and Treatment | The National Academies Press
    https://nap.nationalacademies.org/read/4991/chapter/7
    Studies that have produced rates, or estimated rates, of the incidence of FAS have been carried out in a number of countries. […] In the United States, incidence rates vary widely depending on study site. […] From the clinic-based studies, one can conclude that the prevalence of FAS varies by the prevalence of the problem in the select population served by the hospital or clinic and by the methodology used for case identification and ascertainment. […] Population-based epidemiologic studies using active case ascertainment can assist in addressing some of the criticisms mentioned above, can provide relevant information on the magnitude of the problem in specific communities, and may be more useful for comprehensive community-based prevention efforts. […] The overall significance of these population-based studies is that they may provide more accurate prevalence data and could point the way to more valuable information for comprehensive prevention programs.
  • #48 Fetal Alcohol Syndrome Surveillance: Age of Syndrome Manifestation in Case Ascertainment
    https://pmc.ncbi.nlm.nih.gov/articles/PMC4169739/
    These results indicate that, on average, children were identified through multiple clinical record abstractions as having confirmed or probable FAS shortly after their fourth birthday. […] The implication of this research for surveillance for Fetal Alcohol Syndrome is that a significant amount of time post birth should be allotted for the estimation of true prevalence. […] Methodologically, active surveillance efforts may be best suited for single year birth cohorts with a fixed length of time for case ascertainment or ascertainment at a specific age.
  • #49 Fetal Alcohol Syndrome Surveillance: Age of Syndrome Manifestation in Case Ascertainment
    https://pmc.ncbi.nlm.nih.gov/articles/PMC4169739/
    These results indicate that, on average, children were identified through multiple clinical record abstractions as having confirmed or probable FAS shortly after their fourth birthday. […] The implication of this research for surveillance for Fetal Alcohol Syndrome is that a significant amount of time post birth should be allotted for the estimation of true prevalence. […] Methodologically, active surveillance efforts may be best suited for single year birth cohorts with a fixed length of time for case ascertainment or ascertainment at a specific age.
  • #50 Fetal Alcohol Syndrome Surveillance: Age of Syndrome Manifestation in Case Ascertainment
    https://pmc.ncbi.nlm.nih.gov/articles/PMC4169739/
    These results indicate that, on average, children were identified through multiple clinical record abstractions as having confirmed or probable FAS shortly after their fourth birthday. […] The implication of this research for surveillance for Fetal Alcohol Syndrome is that a significant amount of time post birth should be allotted for the estimation of true prevalence. […] Methodologically, active surveillance efforts may be best suited for single year birth cohorts with a fixed length of time for case ascertainment or ascertainment at a specific age.
  • #51 Fetal Alcohol Syndrome Surveillance: Age of Syndrome Manifestation in Case Ascertainment
    https://pmc.ncbi.nlm.nih.gov/articles/PMC4169739/
    Fetal alcohol syndrome (FAS) is a leading cause of developmental disability. Active public health surveillance through medical record abstraction has been employed to estimate FAS prevalence rates, typically based on birth cohorts. […] The Fetal Alcohol Syndrome Surveillance (FASSLink) Project, funded by the Centers for Disease Control and Prevention (CDC), sought to estimate FAS prevalence rates in eight U.S. states. […] FAS surveillance efforts should screen records of children who are much older than is typical in birth defects surveillance. […] The Fetal Alcohol Syndrome Surveillance (FASSLink) project, funded by the Centers for Disease Control and Prevention (CDC) from 2004 through 2009, sought to determine the prevalence of fetal alcohol syndrome (FAS) among births between 2001 and 2006 in eight states.
  • #52 Fetal alcohol spectrum disorder – Wikipedia
    https://en.wikipedia.org/wiki/Fetal_alcohol_spectrum_disorder
    The rates of alcohol use, FAS, and FASD are likely to be underestimated because of the difficulty in making the diagnosis and the reluctance of clinicians to label children and mothers. […] In a recent count, the prevalence of having any FASD disorder was 1 person out of 20, but some people estimate it could be as high as 1 in 7. […] The rates of FAS and FASD are likely to be underestimated, because of the difficulty in making the diagnosis and the reluctance of clinicians to label children and mothers. […] In the United States, alcohol use at some point during pregnancy is common and appears to be rising in prevalence. […] FASD is estimated to affect between 1-2% and 5% of people in the United States and Western Europe. […] FAS is believed to occur in between 0.2 and 9 per 1,000 live births in the United States.
  • #53 Evaluation of the Public Health Agency of Canada’s Fetal Alcohol Spectrum Disorder Program 2017-18 to 2021-22 – Canada.ca
    https://www.canada.ca/en/public-health/corporate/transparency/corporate-management-reporting/evaluation/evaluation-fetal-alcohol-spectrum-disorder-2017-2018-2021-2022.html
    The national FASD prevalence is unknown because reliable national level surveillance data is not available for determining the magnitude of the population affected by FASD. […] The lack of consistency in prevention messaging, the application of diagnostic guidelines across sociodemographic groups, and the absence of a harm reduction lens in screening approaches. […] The national surveillance of FASD is affected by many challenges, for example: An FASD diagnosis requires a multidisciplinary assessment and knowledge of prenatal alcohol exposure. […] The evaluation assessed progress against achievement of outcomes for PHAC’s main activities community-based funding through the NSPF and surveillance.
  • #54 Italian Guidelines for the diagnosis and treatment of Fetal Alcohol Spectrum Disorders: epidemiology | Rivista di Psichiatria
    https://www.rivistadipsichiatria.it/archivio/4360/articoli/43516/
    FASD prevalence can be up to 40 times higher than in the general population in specific subpopulations. A recent systematic review and meta-analysis shows this elevated prevalence in children in out-of-home care, correctional facilities, special education programs, and specialized clinical settings. […] Current methods for detecting FAS and FASD can underreport prevalence and only identify the most severe cases. It is crucial to identify cases of FAS and FASD in children actively. Without active case ascertainment, many children with FAS and FASD may go undetected, leading to a lack of proper diagnosis and care. […] The epidemiological data related to alcohol exposure in utero, including the prevalence of alcohol consumption during pregnancy and FASD, are often heterogeneous and underestimated. Detecting alcohol consumption is challenging due to social stigma and is particularly sensitive when interviewing pregnant women.
  • #55 Evaluation of the Public Health Agency of Canada’s Fetal Alcohol Spectrum Disorder Program 2017-18 to 2021-22 – Canada.ca
    https://www.canada.ca/en/public-health/corporate/transparency/corporate-management-reporting/evaluation/evaluation-fetal-alcohol-spectrum-disorder-2017-2018-2021-2022.html
    Some funded projects also helped enhance FASD surveillance data while PHAC’s surveillance activities examined various data sources to establish national FASD surveillance. However, the lack of national FASD prevalence data continues to represent a gap, which is further exacerbated by the under-diagnosis and under-reporting of FASD cases. […] Current exploratory activities are necessary precursors to building a national surveillance system. Gathering the necessary data to inform decision making, particularly regarding equity-deserving populations, will require identification of investment in surveillance and collaboration with provinces and territories (P/Ts). […] The evaluation found that some gap areas in FASD could be filled by PHAC given its federal public health role; however, not all activities are integrated.
  • #56 Data and Statistics on FASDs | Fetal Alcohol Spectrum Disorders | CDC
    https://www.cdc.gov/fasd/data/index.html
    FASDs are a group of diagnoses that can occur in a person who was exposed to alcohol before birth. […] The lifetime cost of care for one individual with FAS in 2002 was estimated to be $2 million. […] It is estimated that the cost to the United States for FAS alone is over $4 billion annually. […] People with fetal alcohol spectrum disorders (FASDs) can experience lifelong issues. […] FASDs last a lifetime. […] There is no cure for FASDs, but research shows that early intervention treatment services can improve a child’s development.
  • #57 Data and Statistics on FASDs | Fetal Alcohol Spectrum Disorders | CDC
    https://www.cdc.gov/fasd/data/index.html
    FASDs are a group of diagnoses that can occur in a person who was exposed to alcohol before birth. […] The lifetime cost of care for one individual with FAS in 2002 was estimated to be $2 million. […] It is estimated that the cost to the United States for FAS alone is over $4 billion annually. […] People with fetal alcohol spectrum disorders (FASDs) can experience lifelong issues. […] FASDs last a lifetime. […] There is no cure for FASDs, but research shows that early intervention treatment services can improve a child’s development.
  • #58 Fetal Alcohol Spectrum Disorder | Intellectual Disability and Health
    https://www.intellectualdisability.info/conditions-associated-with-intellectual-disability/articles/fetal-alcohol-spectrum-disorder
    Fetal alcohol spectrum disorders is an umbrella term for a set of disorders caused by the consumption of alcohol by a mother whilst pregnant. […] O’Leary recently summarised the epidemiological research into fetal alcohol spectrum disorders concluding that the estimated worldwide prevalence is around 1 per 100 for fetal alcohol spectrum disorders, making it the most common cause of intellectual difficulties. […] Knowledge levels about fetal alcohol spectrum disorders by the general public and health professionals in the UK are not accurately known. […] The estimated extra cost of fetal alcohol spectrum disorders in USA in has been estimated at $500,000 per individual over a 20 year period. […] For a condition that can be prevented, increasing awareness, education and UK based research will help to allow access to local provisions and could be expected to reduce the prevalence of the condition as well as the human cost in the future.
  • #59 Diagnosis, epidemiology, assessment, pathophysiology, and management of fetal alcohol spectrum disorders
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6995665/
    Prenatal alcohol exposure (PAE) frequently causes neurodevelopmental disorder, yet fetal alcohol spectrum disorders (FASD) are often undiagnosed. Global prevalence rates of 0.77% for FASD and European / North American rates of 25% highlight the need for neurologists to engage in identification, assessment, and treatment of this preventable disorder. […] FASD results from PAE and affects 0.77% of the global population and 20-50% in Europe and North America, with variation by country and epidemiological method. […] The high public health burden of FASD includes lifelong physical and cognitive disability, behavioral disturbance, psychiatric and medical comorbidity, diminished productivity, unemployment, homelessness, and incarceration. […] Recent efforts to improve identification and management of FASD include studies in non-clinically-referred groups, studies of school-based populations, international studies examining high risk populations, advanced 3D imaging of facial characteristics, and new neurobehavioral screening tools.
  • #60 Data and Statistics on FASDs | Fetal Alcohol Spectrum Disorders | CDC
    https://www.cdc.gov/fasd/data/index.html
    FASDs are a group of diagnoses that can occur in a person who was exposed to alcohol before birth. […] The lifetime cost of care for one individual with FAS in 2002 was estimated to be $2 million. […] It is estimated that the cost to the United States for FAS alone is over $4 billion annually. […] People with fetal alcohol spectrum disorders (FASDs) can experience lifelong issues. […] FASDs last a lifetime. […] There is no cure for FASDs, but research shows that early intervention treatment services can improve a child’s development.
  • #61 Data and Statistics on FASDs | Fetal Alcohol Spectrum Disorders | CDC
    https://www.cdc.gov/fasd/data/index.html
    FASDs are a group of diagnoses that can occur in a person who was exposed to alcohol before birth. […] The lifetime cost of care for one individual with FAS in 2002 was estimated to be $2 million. […] It is estimated that the cost to the United States for FAS alone is over $4 billion annually. […] People with fetal alcohol spectrum disorders (FASDs) can experience lifelong issues. […] FASDs last a lifetime. […] There is no cure for FASDs, but research shows that early intervention treatment services can improve a child’s development.
  • #62 Diagnosis, epidemiology, assessment, pathophysiology, and management of fetal alcohol spectrum disorders
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6995665/
    Prenatal alcohol exposure (PAE) frequently causes neurodevelopmental disorder, yet fetal alcohol spectrum disorders (FASD) are often undiagnosed. Global prevalence rates of 0.77% for FASD and European / North American rates of 25% highlight the need for neurologists to engage in identification, assessment, and treatment of this preventable disorder. […] FASD results from PAE and affects 0.77% of the global population and 20-50% in Europe and North America, with variation by country and epidemiological method. […] The high public health burden of FASD includes lifelong physical and cognitive disability, behavioral disturbance, psychiatric and medical comorbidity, diminished productivity, unemployment, homelessness, and incarceration. […] Recent efforts to improve identification and management of FASD include studies in non-clinically-referred groups, studies of school-based populations, international studies examining high risk populations, advanced 3D imaging of facial characteristics, and new neurobehavioral screening tools.
  • #63 ClinMed International Library | Investigating Alcohol Consumption during Pregnancy for the Prevention of Fetal Alcohol Spectrum Disorders (FASD) | Obstetrics and Gynaecology Cases – Reviews |
    https://clinmedjournals.org/articles/ogcr/obstetrics-and-gynaecology-cases-reviews-ogcr-3-076.php?jid=ogcr
    Alcohol exposure causes cognitive and behavioral impairments affecting individuals all their lifelong. […] It has been estimated that during adolescence the following secondary disabilities may occur: mental health problems (90%), trouble with the law (60%), low school proficiency and dropout (60%), inappropriate sexual behavior (49%), alcohol and drug problems (33%). […] Most of the prevalence studies were performed in the United States, mainly registry or clinic based. […] Thus far nearly 15 studies of this kind have been conducted, producing a mean FAS prevalence of 0.85 per 1,000 while information on FASD are not provided. […] In literature, more than 50 clinical studies are reported, showing a mean prevalence rate of 1.8 for FAS and of 6 per 1000 for FASD. […] A minority of studies were performed on nonclinical population, based on an active case ascertainment methodology, where researchers actively evaluate a population in the field to individuate cases.
  • #64 ClinMed International Library | Investigating Alcohol Consumption during Pregnancy for the Prevention of Fetal Alcohol Spectrum Disorders (FASD) | Obstetrics and Gynaecology Cases – Reviews |
    https://clinmedjournals.org/articles/ogcr/obstetrics-and-gynaecology-cases-reviews-ogcr-3-076.php?jid=ogcr
    Alcohol exposure causes cognitive and behavioral impairments affecting individuals all their lifelong. […] It has been estimated that during adolescence the following secondary disabilities may occur: mental health problems (90%), trouble with the law (60%), low school proficiency and dropout (60%), inappropriate sexual behavior (49%), alcohol and drug problems (33%). […] Most of the prevalence studies were performed in the United States, mainly registry or clinic based. […] Thus far nearly 15 studies of this kind have been conducted, producing a mean FAS prevalence of 0.85 per 1,000 while information on FASD are not provided. […] In literature, more than 50 clinical studies are reported, showing a mean prevalence rate of 1.8 for FAS and of 6 per 1000 for FASD. […] A minority of studies were performed on nonclinical population, based on an active case ascertainment methodology, where researchers actively evaluate a population in the field to individuate cases.
  • #65 ClinMed International Library | Investigating Alcohol Consumption during Pregnancy for the Prevention of Fetal Alcohol Spectrum Disorders (FASD) | Obstetrics and Gynaecology Cases – Reviews |
    https://clinmedjournals.org/articles/ogcr/obstetrics-and-gynaecology-cases-reviews-ogcr-3-076.php?jid=ogcr
    Alcohol exposure causes cognitive and behavioral impairments affecting individuals all their lifelong. […] It has been estimated that during adolescence the following secondary disabilities may occur: mental health problems (90%), trouble with the law (60%), low school proficiency and dropout (60%), inappropriate sexual behavior (49%), alcohol and drug problems (33%). […] Most of the prevalence studies were performed in the United States, mainly registry or clinic based. […] Thus far nearly 15 studies of this kind have been conducted, producing a mean FAS prevalence of 0.85 per 1,000 while information on FASD are not provided. […] In literature, more than 50 clinical studies are reported, showing a mean prevalence rate of 1.8 for FAS and of 6 per 1000 for FASD. […] A minority of studies were performed on nonclinical population, based on an active case ascertainment methodology, where researchers actively evaluate a population in the field to individuate cases.
  • #66 ClinMed International Library | Investigating Alcohol Consumption during Pregnancy for the Prevention of Fetal Alcohol Spectrum Disorders (FASD) | Obstetrics and Gynaecology Cases – Reviews |
    https://clinmedjournals.org/articles/ogcr/obstetrics-and-gynaecology-cases-reviews-ogcr-3-076.php?jid=ogcr
    Alcohol exposure causes cognitive and behavioral impairments affecting individuals all their lifelong. […] It has been estimated that during adolescence the following secondary disabilities may occur: mental health problems (90%), trouble with the law (60%), low school proficiency and dropout (60%), inappropriate sexual behavior (49%), alcohol and drug problems (33%). […] Most of the prevalence studies were performed in the United States, mainly registry or clinic based. […] Thus far nearly 15 studies of this kind have been conducted, producing a mean FAS prevalence of 0.85 per 1,000 while information on FASD are not provided. […] In literature, more than 50 clinical studies are reported, showing a mean prevalence rate of 1.8 for FAS and of 6 per 1000 for FASD. […] A minority of studies were performed on nonclinical population, based on an active case ascertainment methodology, where researchers actively evaluate a population in the field to individuate cases.
  • #67 ClinMed International Library | Investigating Alcohol Consumption during Pregnancy for the Prevention of Fetal Alcohol Spectrum Disorders (FASD) | Obstetrics and Gynaecology Cases – Reviews |
    https://clinmedjournals.org/articles/ogcr/obstetrics-and-gynaecology-cases-reviews-ogcr-3-076.php?jid=ogcr
    Alcohol exposure causes cognitive and behavioral impairments affecting individuals all their lifelong. […] It has been estimated that during adolescence the following secondary disabilities may occur: mental health problems (90%), trouble with the law (60%), low school proficiency and dropout (60%), inappropriate sexual behavior (49%), alcohol and drug problems (33%). […] Most of the prevalence studies were performed in the United States, mainly registry or clinic based. […] Thus far nearly 15 studies of this kind have been conducted, producing a mean FAS prevalence of 0.85 per 1,000 while information on FASD are not provided. […] In literature, more than 50 clinical studies are reported, showing a mean prevalence rate of 1.8 for FAS and of 6 per 1000 for FASD. […] A minority of studies were performed on nonclinical population, based on an active case ascertainment methodology, where researchers actively evaluate a population in the field to individuate cases.
  • #68 ClinMed International Library | Investigating Alcohol Consumption during Pregnancy for the Prevention of Fetal Alcohol Spectrum Disorders (FASD) | Obstetrics and Gynaecology Cases – Reviews |
    https://clinmedjournals.org/articles/ogcr/obstetrics-and-gynaecology-cases-reviews-ogcr-3-076.php?jid=ogcr
    Alcohol exposure causes cognitive and behavioral impairments affecting individuals all their lifelong. […] It has been estimated that during adolescence the following secondary disabilities may occur: mental health problems (90%), trouble with the law (60%), low school proficiency and dropout (60%), inappropriate sexual behavior (49%), alcohol and drug problems (33%). […] Most of the prevalence studies were performed in the United States, mainly registry or clinic based. […] Thus far nearly 15 studies of this kind have been conducted, producing a mean FAS prevalence of 0.85 per 1,000 while information on FASD are not provided. […] In literature, more than 50 clinical studies are reported, showing a mean prevalence rate of 1.8 for FAS and of 6 per 1000 for FASD. […] A minority of studies were performed on nonclinical population, based on an active case ascertainment methodology, where researchers actively evaluate a population in the field to individuate cases.
  • #69 Fetal alcohol spectrum disorders: Neurobehavioral profiles | Encyclopedia on Early Childhood Development
    https://www.child-encyclopedia.com/fetal-alcohol-spectrum-disorders-fasd/according-experts/neurobehavioural-profiles-individuals-fetal
    Recent research has addressed whether children with FASD exhibit a unique neurobehavioural profile. The identification of a syndrome-specific profile would improve the diagnosis of children with FASD and inform interventions for all children affected by heavy prenatal alcohol exposure. […] FASD is associated with a number of neurobehavioural impairments including lower overall intelligence and deficits in executive functioning, learning and memory, language, visual-spatial functioning, and attention. […] Prenatal exposure to alcohol affects 1.1 to 5.0% of the population and leads to a spectrum of neurobehavioural consequences, including decreased overall intelligence and specific deficits in executive functioning, learning, memory, language, visual-spatial skills, and attention. Children with FASD display deficits in daily living skills and are at a higher risk for problem behaviours. […] The identification of a syndrome-specific profile would improve diagnosis of children with heavy prenatal exposure to alcohol, especially for the majority of children with FASD who do not display the facial dysmorphology.
  • #70 Fetal alcohol spectrum disorders: Neurobehavioral profiles | Encyclopedia on Early Childhood Development
    https://www.child-encyclopedia.com/fetal-alcohol-spectrum-disorders-fasd/according-experts/neurobehavioural-profiles-individuals-fetal
    Recent research has addressed whether children with FASD exhibit a unique neurobehavioural profile. The identification of a syndrome-specific profile would improve the diagnosis of children with FASD and inform interventions for all children affected by heavy prenatal alcohol exposure. […] FASD is associated with a number of neurobehavioural impairments including lower overall intelligence and deficits in executive functioning, learning and memory, language, visual-spatial functioning, and attention. […] Prenatal exposure to alcohol affects 1.1 to 5.0% of the population and leads to a spectrum of neurobehavioural consequences, including decreased overall intelligence and specific deficits in executive functioning, learning, memory, language, visual-spatial skills, and attention. Children with FASD display deficits in daily living skills and are at a higher risk for problem behaviours. […] The identification of a syndrome-specific profile would improve diagnosis of children with heavy prenatal exposure to alcohol, especially for the majority of children with FASD who do not display the facial dysmorphology.
  • #71 What’s New
    https://www.cdph.ca.gov/Programs/CCDPHP/sapb/Pages/FASDs.aspx
    Yes, FASDs are preventable if a baby is not exposed to alcohol before birth. Anyone is at risk of giving birth to a baby with an FASD if they consume alcohol during pregnancy. […] There is no safe amount of alcohol that is considered safe at any stage during pregnancy. […] There is no safe timeframe during pregnancy or while trying to get pregnant to drink alcohol. Alcohol can disrupt fetal development at any stage of pregnancy, including before a person knows they’re pregnant since individuals could get pregnant and not know for up to 4 to 6 weeks. […] There is no safe type of alcohol use during pregnancy or while trying to get pregnant. All types of alcohol are equally harmful during pregnancy, including all wines and beer. […] Because there is no safe amount, timeframe, or type of alcohol use during pregnancy, people who are pregnant, think they might be pregnant, or are trying to become pregnant should not drink alcohol.
  • #72 Fetal Alcohol Syndrome and Fetal Alcohol Spectrum Disorders | AAFP
    https://www.aafp.org/pubs/afp/issues/2017/1015/p515.html
    Early intervention is necessary to optimize health outcomes. […] The Centers for Disease Control and Prevention, the American Academy of Family Physicians, the American Academy of Pediatrics, and the American Congress of Obstetricians and Gynecologists recognize no safe amount of alcohol consumption during pregnancy and recommend complete abstinence. […] Contraception should be offered to women of child-bearing age who drink; if they desire pregnancy, abstinence from alcohol should be recommended. […] If alcohol use in pregnancy is identified, physicians should recommend cessation and offer group-based interventions such as Alcoholics Anonymous and alcohol rehabilitation centers.
  • #73 What’s New
    https://www.cdph.ca.gov/Programs/CCDPHP/sapb/Pages/FASDs.aspx
    Yes, FASDs are preventable if a baby is not exposed to alcohol before birth. Anyone is at risk of giving birth to a baby with an FASD if they consume alcohol during pregnancy. […] There is no safe amount of alcohol that is considered safe at any stage during pregnancy. […] There is no safe timeframe during pregnancy or while trying to get pregnant to drink alcohol. Alcohol can disrupt fetal development at any stage of pregnancy, including before a person knows they’re pregnant since individuals could get pregnant and not know for up to 4 to 6 weeks. […] There is no safe type of alcohol use during pregnancy or while trying to get pregnant. All types of alcohol are equally harmful during pregnancy, including all wines and beer. […] Because there is no safe amount, timeframe, or type of alcohol use during pregnancy, people who are pregnant, think they might be pregnant, or are trying to become pregnant should not drink alcohol.
  • #74 What’s New
    https://www.cdph.ca.gov/Programs/CCDPHP/sapb/Pages/FASDs.aspx
    Yes, FASDs are preventable if a baby is not exposed to alcohol before birth. Anyone is at risk of giving birth to a baby with an FASD if they consume alcohol during pregnancy. […] There is no safe amount of alcohol that is considered safe at any stage during pregnancy. […] There is no safe timeframe during pregnancy or while trying to get pregnant to drink alcohol. Alcohol can disrupt fetal development at any stage of pregnancy, including before a person knows they’re pregnant since individuals could get pregnant and not know for up to 4 to 6 weeks. […] There is no safe type of alcohol use during pregnancy or while trying to get pregnant. All types of alcohol are equally harmful during pregnancy, including all wines and beer. […] Because there is no safe amount, timeframe, or type of alcohol use during pregnancy, people who are pregnant, think they might be pregnant, or are trying to become pregnant should not drink alcohol.
  • #75 What’s New
    https://www.cdph.ca.gov/Programs/CCDPHP/sapb/Pages/FASDs.aspx
    Yes, FASDs are preventable if a baby is not exposed to alcohol before birth. Anyone is at risk of giving birth to a baby with an FASD if they consume alcohol during pregnancy. […] There is no safe amount of alcohol that is considered safe at any stage during pregnancy. […] There is no safe timeframe during pregnancy or while trying to get pregnant to drink alcohol. Alcohol can disrupt fetal development at any stage of pregnancy, including before a person knows they’re pregnant since individuals could get pregnant and not know for up to 4 to 6 weeks. […] There is no safe type of alcohol use during pregnancy or while trying to get pregnant. All types of alcohol are equally harmful during pregnancy, including all wines and beer. […] Because there is no safe amount, timeframe, or type of alcohol use during pregnancy, people who are pregnant, think they might be pregnant, or are trying to become pregnant should not drink alcohol.
  • #76 ClinMed International Library | Investigating Alcohol Consumption during Pregnancy for the Prevention of Fetal Alcohol Spectrum Disorders (FASD) | Obstetrics and Gynaecology Cases – Reviews |
    https://clinmedjournals.org/articles/ogcr/obstetrics-and-gynaecology-cases-reviews-ogcr-3-076.php?jid=ogcr
    Prevalence of women drinking during pregnancy in the US decreased over the last decade, from 20% prior to 2001 to 10.2% in 2011-2013 while in Europe rates range from 25% in Spain to 79% in the United Kingdom and Ireland. […] Thus, the identification of women still drinking during pregnancy has main implications for prevention. […] Early detection of alcohol consumption during pregnancy is essential both for its preventive and therapeutic implications. […] The burden of lifelong disabilities caused by alcohol exposure during pregnancy is extreme at individual, familial and societal level. […] Public agencies all over the world underline the crucial importance of prevention through the enactment of laws on labeling alcoholic beverages and the release of health statements recommending total abstinence from alcohol during pregnancy and lactation as the unique way of prevention.
  • #77 ClinMed International Library | Investigating Alcohol Consumption during Pregnancy for the Prevention of Fetal Alcohol Spectrum Disorders (FASD) | Obstetrics and Gynaecology Cases – Reviews |
    https://clinmedjournals.org/articles/ogcr/obstetrics-and-gynaecology-cases-reviews-ogcr-3-076.php?jid=ogcr
    Professionals’ recommendations and early identification of at-risk women are crucial, as fetal alcohol effects are 100% preventable just suspending consumption during pre-conception time and pregnancy. […] Even if differences may exist in the main description of the syndrome, the following features are commonly recognized in children prenatally exposed to alcohol: specific facial anomalies, growth delay, central nervous system (CNS) problems and intellectual disabilities and behavioral problems. […] The IOM describes the following revised diagnostic criteria: A full syndrome (FAS) that includes, at least, two of the above-mentioned facial features; growth deficiencies and CNS problems, including structural brain anomalies or head circumference equal or below the tenth percentile. […] The term FASD has recently been introduced as a nondiagnostic term to comprehend the whole range of possible alcohol-related damage in children exposed, including also effects like abortion.
  • #78 5 Epidemiology and Surveillance of Fetal Alcohol Syndrome | Fetal Alcohol Syndrome: Diagnosis, Epidemiology, Prevention, and Treatment | The National Academies Press
    https://nap.nationalacademies.org/read/4991/chapter/7
    The Centers for Disease Control and Prevention monitors the rate of FAS in two birth defects surveillance programs. […] The overall rate of FAS was 2.97 per 1,000 for Native Americans, 0.6 per 1,000 for African Americans, 0.09 for Caucasians, 0.08 for Hispanics, and 0.03 for Asians. […] A subsequent CDC article on data from the BDMP estimated the overall incidence of FAS from 1979 to 1993 at 0.22 per 1,000. […] The CDC’s Metropolitan Atlanta Congenital Defects Program (MACDP) is a population-based registry that identifies children diagnosed with birth defects during the neonatal and infancy periods. […] In general, the surveillance of FAS is similar in these other systems. […] Given also that FAS is a complex diagnosis, it may go unrecognized at birth. […] Thus, registry-based estimates of FAS prevalence can be expected to be gross underestimates.
  • #79 5 Epidemiology and Surveillance of Fetal Alcohol Syndrome | Fetal Alcohol Syndrome: Diagnosis, Epidemiology, Prevention, and Treatment | The National Academies Press
    https://nap.nationalacademies.org/read/4991/chapter/7
    The Centers for Disease Control and Prevention monitors the rate of FAS in two birth defects surveillance programs. […] The overall rate of FAS was 2.97 per 1,000 for Native Americans, 0.6 per 1,000 for African Americans, 0.09 for Caucasians, 0.08 for Hispanics, and 0.03 for Asians. […] A subsequent CDC article on data from the BDMP estimated the overall incidence of FAS from 1979 to 1993 at 0.22 per 1,000. […] The CDC’s Metropolitan Atlanta Congenital Defects Program (MACDP) is a population-based registry that identifies children diagnosed with birth defects during the neonatal and infancy periods. […] In general, the surveillance of FAS is similar in these other systems. […] Given also that FAS is a complex diagnosis, it may go unrecognized at birth. […] Thus, registry-based estimates of FAS prevalence can be expected to be gross underestimates.
  • #80 5 Epidemiology and Surveillance of Fetal Alcohol Syndrome | Fetal Alcohol Syndrome: Diagnosis, Epidemiology, Prevention, and Treatment | The National Academies Press
    https://nap.nationalacademies.org/read/4991/chapter/7
    The Centers for Disease Control and Prevention monitors the rate of FAS in two birth defects surveillance programs. […] The overall rate of FAS was 2.97 per 1,000 for Native Americans, 0.6 per 1,000 for African Americans, 0.09 for Caucasians, 0.08 for Hispanics, and 0.03 for Asians. […] A subsequent CDC article on data from the BDMP estimated the overall incidence of FAS from 1979 to 1993 at 0.22 per 1,000. […] The CDC’s Metropolitan Atlanta Congenital Defects Program (MACDP) is a population-based registry that identifies children diagnosed with birth defects during the neonatal and infancy periods. […] In general, the surveillance of FAS is similar in these other systems. […] Given also that FAS is a complex diagnosis, it may go unrecognized at birth. […] Thus, registry-based estimates of FAS prevalence can be expected to be gross underestimates.
  • #81 FAS Surveillance
    https://depts.washington.edu/fasdpn/htmls/surveillance.htm
    Surveillance Listed below are links to agencies and programs currently engaged in surveillance of fetal alcohol spectrum disorders and maternal use of alcohol during pregnancy. The FAS DPN tracks the annual prevalence of FAS by birth cohort among all children enrolled in the Foster Care Passport Program FAS Screening Program. This surveillance activity recently documented a statistically significant decline in the prevalence of FAS among the children born from 1993 to 1998. […] PRAMS is a CDC-sponsored, ongoing, population-based surveillance system designed to monitor self-reported maternal behaviors (including alcohol use) that occur before, during and after pregnancy. […] The Washington State Birth Defects Surveillance System was an active surveillance system form 1986 to 1991. Since then, the system has been passive, relying on hospitals to report cases of children with birth defects. The FAS Diagnostic Prevention Network (FAS DPN) reports all cases of FAS to the State Birth Defects Surveillance Program.
  • #82 FAS Surveillance
    https://depts.washington.edu/fasdpn/htmls/surveillance.htm
    Surveillance Listed below are links to agencies and programs currently engaged in surveillance of fetal alcohol spectrum disorders and maternal use of alcohol during pregnancy. The FAS DPN tracks the annual prevalence of FAS by birth cohort among all children enrolled in the Foster Care Passport Program FAS Screening Program. This surveillance activity recently documented a statistically significant decline in the prevalence of FAS among the children born from 1993 to 1998. […] PRAMS is a CDC-sponsored, ongoing, population-based surveillance system designed to monitor self-reported maternal behaviors (including alcohol use) that occur before, during and after pregnancy. […] The Washington State Birth Defects Surveillance System was an active surveillance system form 1986 to 1991. Since then, the system has been passive, relying on hospitals to report cases of children with birth defects. The FAS Diagnostic Prevention Network (FAS DPN) reports all cases of FAS to the State Birth Defects Surveillance Program.
  • #83 IJPDS International Journal of Population Data Science
    https://ijpds.org/article/view/1703
    National FASD surveillance: Australian Paediatric Surveillance Unit and FASD Registry. […] Earlier research by CRE members indicated that Australian clinicians were unskilled or unwilling to make a FASD diagnosis and did not know where to refer for assessment or FASD management, leading government to fund diagnostic guidelines. […] Funding was also provided for national prospective surveillance of FASD through the Australian Paediatric Surveillance Unit and development of the FASD Australian Registry.
  • #84 Evaluation of the Public Health Agency of Canada’s Fetal Alcohol Spectrum Disorder Program 2017-18 to 2021-22 – Canada.ca
    https://www.canada.ca/en/public-health/corporate/transparency/corporate-management-reporting/evaluation/evaluation-fetal-alcohol-spectrum-disorder-2017-2018-2021-2022.html
    Fetal Alcohol Spectrum Disorder (FASD) is a diagnostic term that describes the impact that prenatal alcohol exposure has on the brain and body. The goal of the FASD Program is to provide strategic federal leadership and coordination, to prevent FASD, and to promote positive health and social outcomes for those with FASD. PHAC’s Centre for Surveillance and Applied Research (CSAR), in collaboration with key stakeholders, conducts surveillance and monitoring to progress toward building national FASD surveillance data. […] Despite having ambitious objectives, FASD-dedicated funding is limited. Important gaps remain and some appear to align with the federal public health role in the areas of strengthening surveillance, national strategic planning, stakeholder engagement and collaboration, documenting promising practices, and supporting guideline development and dissemination.
  • #85 Diagnosis, epidemiology, assessment, pathophysiology, and management of fetal alcohol spectrum disorders
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6995665/
    Prenatal alcohol exposure (PAE) frequently causes neurodevelopmental disorder, yet fetal alcohol spectrum disorders (FASD) are often undiagnosed. Global prevalence rates of 0.77% for FASD and European / North American rates of 25% highlight the need for neurologists to engage in identification, assessment, and treatment of this preventable disorder. […] FASD results from PAE and affects 0.77% of the global population and 20-50% in Europe and North America, with variation by country and epidemiological method. […] The high public health burden of FASD includes lifelong physical and cognitive disability, behavioral disturbance, psychiatric and medical comorbidity, diminished productivity, unemployment, homelessness, and incarceration. […] Recent efforts to improve identification and management of FASD include studies in non-clinically-referred groups, studies of school-based populations, international studies examining high risk populations, advanced 3D imaging of facial characteristics, and new neurobehavioral screening tools.
  • #86 Diagnosis, epidemiology, assessment, pathophysiology, and management of fetal alcohol spectrum disorders
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6995665/
    Prenatal alcohol exposure (PAE) frequently causes neurodevelopmental disorder, yet fetal alcohol spectrum disorders (FASD) are often undiagnosed. Global prevalence rates of 0.77% for FASD and European / North American rates of 25% highlight the need for neurologists to engage in identification, assessment, and treatment of this preventable disorder. […] FASD results from PAE and affects 0.77% of the global population and 20-50% in Europe and North America, with variation by country and epidemiological method. […] The high public health burden of FASD includes lifelong physical and cognitive disability, behavioral disturbance, psychiatric and medical comorbidity, diminished productivity, unemployment, homelessness, and incarceration. […] Recent efforts to improve identification and management of FASD include studies in non-clinically-referred groups, studies of school-based populations, international studies examining high risk populations, advanced 3D imaging of facial characteristics, and new neurobehavioral screening tools.
  • #87 Diagnosis, epidemiology, assessment, pathophysiology, and management of fetal alcohol spectrum disorders
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6995665/
    Prenatal alcohol exposure (PAE) frequently causes neurodevelopmental disorder, yet fetal alcohol spectrum disorders (FASD) are often undiagnosed. Global prevalence rates of 0.77% for FASD and European / North American rates of 25% highlight the need for neurologists to engage in identification, assessment, and treatment of this preventable disorder. […] FASD results from PAE and affects 0.77% of the global population and 20-50% in Europe and North America, with variation by country and epidemiological method. […] The high public health burden of FASD includes lifelong physical and cognitive disability, behavioral disturbance, psychiatric and medical comorbidity, diminished productivity, unemployment, homelessness, and incarceration. […] Recent efforts to improve identification and management of FASD include studies in non-clinically-referred groups, studies of school-based populations, international studies examining high risk populations, advanced 3D imaging of facial characteristics, and new neurobehavioral screening tools.
  • #88 Diagnosis, epidemiology, assessment, pathophysiology, and management of fetal alcohol spectrum disorders
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6995665/
    Prenatal alcohol exposure (PAE) frequently causes neurodevelopmental disorder, yet fetal alcohol spectrum disorders (FASD) are often undiagnosed. Global prevalence rates of 0.77% for FASD and European / North American rates of 25% highlight the need for neurologists to engage in identification, assessment, and treatment of this preventable disorder. […] FASD results from PAE and affects 0.77% of the global population and 20-50% in Europe and North America, with variation by country and epidemiological method. […] The high public health burden of FASD includes lifelong physical and cognitive disability, behavioral disturbance, psychiatric and medical comorbidity, diminished productivity, unemployment, homelessness, and incarceration. […] Recent efforts to improve identification and management of FASD include studies in non-clinically-referred groups, studies of school-based populations, international studies examining high risk populations, advanced 3D imaging of facial characteristics, and new neurobehavioral screening tools.
  • #89 Diagnosis, epidemiology, assessment, pathophysiology, and management of fetal alcohol spectrum disorders
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6995665/
    Prenatal alcohol exposure (PAE) frequently causes neurodevelopmental disorder, yet fetal alcohol spectrum disorders (FASD) are often undiagnosed. Global prevalence rates of 0.77% for FASD and European / North American rates of 25% highlight the need for neurologists to engage in identification, assessment, and treatment of this preventable disorder. […] FASD results from PAE and affects 0.77% of the global population and 20-50% in Europe and North America, with variation by country and epidemiological method. […] The high public health burden of FASD includes lifelong physical and cognitive disability, behavioral disturbance, psychiatric and medical comorbidity, diminished productivity, unemployment, homelessness, and incarceration. […] Recent efforts to improve identification and management of FASD include studies in non-clinically-referred groups, studies of school-based populations, international studies examining high risk populations, advanced 3D imaging of facial characteristics, and new neurobehavioral screening tools.
  • #90 Diagnosis, epidemiology, assessment, pathophysiology, and management of fetal alcohol spectrum disorders
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6995665/
    Prenatal alcohol exposure (PAE) frequently causes neurodevelopmental disorder, yet fetal alcohol spectrum disorders (FASD) are often undiagnosed. Global prevalence rates of 0.77% for FASD and European / North American rates of 25% highlight the need for neurologists to engage in identification, assessment, and treatment of this preventable disorder. […] FASD results from PAE and affects 0.77% of the global population and 20-50% in Europe and North America, with variation by country and epidemiological method. […] The high public health burden of FASD includes lifelong physical and cognitive disability, behavioral disturbance, psychiatric and medical comorbidity, diminished productivity, unemployment, homelessness, and incarceration. […] Recent efforts to improve identification and management of FASD include studies in non-clinically-referred groups, studies of school-based populations, international studies examining high risk populations, advanced 3D imaging of facial characteristics, and new neurobehavioral screening tools.
  • #91
    https://beta.cdc.gov/mmwr/preview/mmwrhtml/00050021.htm
    This report presents a multiple-source method for FAS surveillance that is more complete than previous methods and that enables comparison of rates between states. […] During 1981-1989, MACDP and MADDSP combined identified 92 children with possible FAS: MACDP uniquely identified 50 (54%) of these possible cases; MADDSP uniquely identified 31 (34%); and both registries identified 11 (12%). […] The observed prevalence of full FAS was 1.0 cases per 10,000 live-born infants, and the observed prevalence of both full and partial FAS was 2.5 cases per 10,000. […] The estimated prevalence derived from capture-recapture analysis was 5.1 cases of full and partial FAS per 10,000. […] During 1981-1989, prevalence of full or full and partial FAS remained stable. […] The findings in this report indicate that, based on case confirmations conducted in 1997, the observed prevalence of full FAS among children born in Atlanta during 1981-1989 was 1.0 cases per 10,000 live-born infants and 2.5 per 10,000 for both full and partial FAS. […] The advantages of using existing multiple data sources to calculate the prevalence of FAS are the feasibility of the method and more complete casefinding. […] Surveillance is necessary to monitor patterns of FAS and the impact of prevention efforts.
  • #92
    https://beta.cdc.gov/mmwr/preview/mmwrhtml/00050021.htm
    This report presents a multiple-source method for FAS surveillance that is more complete than previous methods and that enables comparison of rates between states. […] During 1981-1989, MACDP and MADDSP combined identified 92 children with possible FAS: MACDP uniquely identified 50 (54%) of these possible cases; MADDSP uniquely identified 31 (34%); and both registries identified 11 (12%). […] The observed prevalence of full FAS was 1.0 cases per 10,000 live-born infants, and the observed prevalence of both full and partial FAS was 2.5 cases per 10,000. […] The estimated prevalence derived from capture-recapture analysis was 5.1 cases of full and partial FAS per 10,000. […] During 1981-1989, prevalence of full or full and partial FAS remained stable. […] The findings in this report indicate that, based on case confirmations conducted in 1997, the observed prevalence of full FAS among children born in Atlanta during 1981-1989 was 1.0 cases per 10,000 live-born infants and 2.5 per 10,000 for both full and partial FAS. […] The advantages of using existing multiple data sources to calculate the prevalence of FAS are the feasibility of the method and more complete casefinding. […] Surveillance is necessary to monitor patterns of FAS and the impact of prevention efforts.
  • #93
    https://www.gov.uk/government/publications/fetal-alcohol-spectrum-disorder-health-needs-assessment/fetal-alcohol-spectrum-disorder-health-needs-assessment
    The first national effort to quantify FASD in the UK was published late 2018. The study found a screening prevalence range in the UK of 6% to 17%. […] A prevalence study in primary schools in Greater Manchester began in 2019, led by the University of Salford. This was the first UK active ascertainment study, which is the most reliable approach to assessing prevalence. […] There are currently no prevalence studies for FASD in the UK. […] The lack of reliable prevalence estimates for England and the UK present a significant barrier to understanding and meeting the needs of those living with the condition, their families and carers. […] There is an immediate need for wider UK population-based estimates of FASD prevalence, using active case ascertainment studies.
  • #94 FASD prevalence among children and youth: results from the 2019 Canadian Health Survey on Children and Youth – Canada.ca
    https://www.canada.ca/en/public-health/services/reports-publications/health-promotion-chronic-disease-prevention-canada-research-policy-practice/vol-41-no-9-2021/fasd-prevalence-children-youth-2019.html
    The prevalence of FASD among Canadian children and youth living in private dwellings was 1 per 1000 (0.1%). […] The prevalence was significantly higher among those who identified as Indigenous and lived off reserve (1.2%). […] These findings are in keeping with FASD prevalence studies that used similar passive surveillance methods. […] We need national surveillance of FASD to better understand the prevalence of this condition. […] The lack of national FASD prevalence estimates represents an important knowledge gap in informing the public health response. […] Based on the data from the 2019 CHSCY, the estimated national prevalence of diagnosed FASD among children and youth aged 1 to 17 years is 1 per 1000 or 0.1%. […] Canadian prevalence studies of FASD have employed various methods including clinical examinations and active case ascertainment while focussing on different population groups, jurisdictions and age ranges.
  • #95 FASD prevalence among children and youth: results from the 2019 Canadian Health Survey on Children and Youth – Canada.ca
    https://www.canada.ca/en/public-health/services/reports-publications/health-promotion-chronic-disease-prevention-canada-research-policy-practice/vol-41-no-9-2021/fasd-prevalence-children-youth-2019.html
    Canadian children and youth who identified as Indigenous and who lived off reserve had a significantly higher prevalence of FASD than those who did not (1.2% versus 0.1%). […] National surveillance of FASD is needed to gain a better understanding of the estimated prevalence and provide baseline numbers against which future public health actions can be evaluated.
  • #96 Fetal alcohol spectrum disorders: Prevention | Encyclopedia on Early Childhood Development
    https://www.child-encyclopedia.com/fetal-alcohol-spectrum-disorders-fasd/according-experts/prevention-fetal-alcohol-spectrum-disorders
    Survey results from the Centers for Disease Control and Prevention (CDC) using the Behavioral Risk Factor Surveillance System (BRFSS) report long-term trends in high rates of alcohol use among women of childbearing age (18-44) in the U.S. […] Between 1991 and 2005, approximately 55% of non-pregnant, and 11% of pregnant women, reported alcohol use in the past month. […] As stated earlier, prenatal alcohol exposure is a common occurrence in the U.S. with 1 in 8 pregnant women self-reporting alcohol use during pregnancy. […] While there is a significant reduction in alcohol use after pregnancy recognition occurs overall, there is evidence that many women continue to drink while trying to get pregnant and after pregnancy recognition. […] Efficient population-based surveillance systems need to be developed to provide information on the full impact of prenatal alcohol exposure providing information for action and to build the public will and support necessary to prevent FASDs.
  • #97 5 Epidemiology and Surveillance of Fetal Alcohol Syndrome | Fetal Alcohol Syndrome: Diagnosis, Epidemiology, Prevention, and Treatment | The National Academies Press
    https://nap.nationalacademies.org/read/4991/chapter/7
    The success of any public health program can be measured by comparing the incidence or prevalence of a particular societal problem before that program was implemented with its incidence or prevalence after implementation. […] Epidemiology and surveillance of fetal alcohol syndrome (FAS), alcohol-related birth defects (ARBD), and alcohol-related neurodevelopmental disorder (ARND) are ongoing but are currently hampered by inconsistent methods and criteria for gathering the appropriate data. […] The literature on the epidemiology of FAS and ARBD or ARND is extensive and complicated by differences in the definition of outcomes in this evolving field. […] The incidence of FAS has been estimated from data of three main types: information collected passively for another or for many purposes, such as birth defects registries; information gathered either retrospectively or prospectively from hospital or clinic-based populations, including subjects in controlled epidemiologic studies of the effects of maternal substance abuse; and population-based active case ascertainment.
  • #98 5 Epidemiology and Surveillance of Fetal Alcohol Syndrome | Fetal Alcohol Syndrome: Diagnosis, Epidemiology, Prevention, and Treatment | The National Academies Press
    https://nap.nationalacademies.org/read/4991/chapter/7
    The success of any public health program can be measured by comparing the incidence or prevalence of a particular societal problem before that program was implemented with its incidence or prevalence after implementation. […] Epidemiology and surveillance of fetal alcohol syndrome (FAS), alcohol-related birth defects (ARBD), and alcohol-related neurodevelopmental disorder (ARND) are ongoing but are currently hampered by inconsistent methods and criteria for gathering the appropriate data. […] The literature on the epidemiology of FAS and ARBD or ARND is extensive and complicated by differences in the definition of outcomes in this evolving field. […] The incidence of FAS has been estimated from data of three main types: information collected passively for another or for many purposes, such as birth defects registries; information gathered either retrospectively or prospectively from hospital or clinic-based populations, including subjects in controlled epidemiologic studies of the effects of maternal substance abuse; and population-based active case ascertainment.
  • #99 Italian Guidelines for the diagnosis and treatment of Fetal Alcohol Spectrum Disorders: epidemiology | Rivista di Psichiatria
    https://www.rivistadipsichiatria.it/archivio/4360/articoli/43516/
    FASD prevalence can be up to 40 times higher than in the general population in specific subpopulations. A recent systematic review and meta-analysis shows this elevated prevalence in children in out-of-home care, correctional facilities, special education programs, and specialized clinical settings. […] Current methods for detecting FAS and FASD can underreport prevalence and only identify the most severe cases. It is crucial to identify cases of FAS and FASD in children actively. Without active case ascertainment, many children with FAS and FASD may go undetected, leading to a lack of proper diagnosis and care. […] The epidemiological data related to alcohol exposure in utero, including the prevalence of alcohol consumption during pregnancy and FASD, are often heterogeneous and underestimated. Detecting alcohol consumption is challenging due to social stigma and is particularly sensitive when interviewing pregnant women.
  • #100 Fetal alcohol spectrum disorders prevention and clinical guidelines research – workshop report | BMC Proceedings | Full Text
    https://bmcproc.biomedcentral.com/articles/10.1186/s12919-024-00298-x
    The most influential known risk factor is prenatal alcohol exposure. […] Maternal risk factors for FASD encompass a woman’s general physical and mental health; the type, quantity, frequency, and gestational timing of alcohol use; and social norms and practices. […] Public health surveillance of children with FASD is a priority for the CDC, but just as there is no standard research definition for FASD, there is also no standard surveillance case definition. […] The environmental scan revealed that there are clinical practice guidelines, policies, and interventions to screen for and address alcohol and substance use and disorder in pregnancy and pre-pregnancy, which are largely aligned with national recommendations. […] However, the researchers found that despite these resources, unhealthy alcohol use continues. […] Notably, researchers found that there are no FASD-specific resources. […] Together, findings point to a need for FASD-specific screening, support, and services, along with programs to raise awareness of and change the messaging and culture around alcohol use in the military.
  • #101 Diagnostic Issues Affecting the Epidemiology of Fetal Alcohol Spectrum Disorders | Journal of Population Therapeutics and Clinical Pharmacology
    https://jptcp.com/index.php/jptcp/article/view/596
    Epidemiological measures of the prevalence of fetal alcohol spectrum disorders (FASD) vary greatly in the literature. […] Estimates of the prevalence of FASD primarily depend on the diagnostic criteria currently available. […] To date, the Canadian guidelines represent the only guidelines that have pushed for a uniform diagnostic capacity through harmonizing the IoM and 4-Digit Diagnostic Code criteria. […] There are profound implications of relaxed and strict diagnostic approaches on FAS prevalence reporting in the literature. […] Discrepancies in the criteria pose a danger to the validity of FASD diagnoses with respect to inaccurate estimates of incidence and prevalence. […] In turn, these discrepancies risk compromising the future healthcare of affected individuals with regards to intervention, counselling and treatment.
  • #102 Diagnosis, epidemiology, assessment, pathophysiology, and management of fetal alcohol spectrum disorders
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6995665/
    Diagnosing FASD in children and adults plays a critical role in identifying co-morbid and co-occurring conditions and accessing vocational support, housing and financial assistance, psychological interventions, and specialized legal counseling. […] FASD represents a global public health problem that remains under-recognized and under-diagnosed despite its high prevalence and cost to society.
  • #103 Fetal Alcohol Syndrome and Fetal Alcohol Spectrum Disorders | AAFP
    https://www.aafp.org/pubs/afp/issues/2017/1015/p515.html
    Early intervention is necessary to optimize health outcomes. […] The Centers for Disease Control and Prevention, the American Academy of Family Physicians, the American Academy of Pediatrics, and the American Congress of Obstetricians and Gynecologists recognize no safe amount of alcohol consumption during pregnancy and recommend complete abstinence. […] Contraception should be offered to women of child-bearing age who drink; if they desire pregnancy, abstinence from alcohol should be recommended. […] If alcohol use in pregnancy is identified, physicians should recommend cessation and offer group-based interventions such as Alcoholics Anonymous and alcohol rehabilitation centers.
  • #104 Fetal alcohol spectrum disorders in Australia – the future is prevention «
    https://www.phrp.com.au/issues/march-2015-volume-25-issue-2/fetal-alcohol-spectrum-disorders-in-australia-the-future-is-prevention/
    Fetal alcohol spectrum disorders (FASD) are increasingly recognised throughout Australia as important, but preventable, disorders that result in lifelong problems with health and learning, mental health, behaviour and substance misuse. […] A federal parliamentary inquiry into FASD (2011), development of an Australian Government action plan to prevent FASD (2013) and the announcement in June 2014 of government funding to progress the plan and appoint a National FASD Technical Network have focused attention on the need for FASD prevention in Australia. […] Prevention should be evidence based and evaluated, but Australia lacks FASD surveillance and a national register to measure the success of prevention programs. […] Prevention strategies should be evidence based and evaluated; however, Australia lacks FASD surveillance and a national FASD register. […] Although the young brain is adaptable, prenatal brain injury cannot be reversed so, for FASD, the future must be prevention.
  • #105 Fetal Alcohol Spectrum Disorders
    https://www.aap.org/en/patient-care/fetal-alcohol-spectrum-disorders/?srsltid=AfmBOor4nxTA-p7M92c-WYlmwxmNIzx6izEsM5Sf24WndXIZv5HGAVhd
    Fetal Alcohol Spectrum Disorder is an umbrella term describing a broad range of adverse developmental effects that can occur in an individual with prenatal exposure to alcohol. […] It is not known how many people in the United States have an FASD. Several initial studies, using active case findings of school-aged children, indicate that 1% to 5% of children in the United States may have an FASD. […] Centers for Disease Control and Prevention data indicate that approximately 12% of pregnancies may have alcohol exposure, which can lead to FASD birth defects. […] The protective effect of early FASD diagnosis can reduce the risk of additional disabilities and mitigate lifelong consequences. […] Ongoing care in a supportive pediatric home is an important component to achieving health and wellbeing for any child with an FASD and their family.
  • #106 Fetal Alcohol Spectrum Disorders
    https://www.aap.org/en/patient-care/fetal-alcohol-spectrum-disorders/?srsltid=AfmBOor4nxTA-p7M92c-WYlmwxmNIzx6izEsM5Sf24WndXIZv5HGAVhd
    Fetal Alcohol Spectrum Disorder is an umbrella term describing a broad range of adverse developmental effects that can occur in an individual with prenatal exposure to alcohol. […] It is not known how many people in the United States have an FASD. Several initial studies, using active case findings of school-aged children, indicate that 1% to 5% of children in the United States may have an FASD. […] Centers for Disease Control and Prevention data indicate that approximately 12% of pregnancies may have alcohol exposure, which can lead to FASD birth defects. […] The protective effect of early FASD diagnosis can reduce the risk of additional disabilities and mitigate lifelong consequences. […] Ongoing care in a supportive pediatric home is an important component to achieving health and wellbeing for any child with an FASD and their family.
  • #107 Fetal Alcohol Spectrum Disorder (FASD) – Health Care for Adults with Intellectual and Developmental Disabilities
    https://iddtoolkit.vkcsites.org/health-watch-tables/fetal-alcohol-spectrum-disorder-fasd/
    Prenatal alcohol exposure The range of deficits in FASD is associated with many factors, including the amount, time and frequency of exposure, as well as the state of health/nutrition of the mother and the genetic makeup of the mother and the fetus. There is no time during pregnancy when it is shown to be safe for mothers to consume alcohol. While binge drinking is especially dangerous, no amount of alcohol has been shown to be safe for all women. […] Most individuals with FASD have an invisible disorder and 50% meet current definitions of developmental/intellectual disability.11 […] However, The diagnosis can lead to a paradigm shift in attitude and perception towards the affected individual from one of a difficult individual or sociopath to that of an individual who is neurologically impaired and who needs appropriate assistance with specific management and treatment.11
  • #108 Fetal Alcohol Syndrome and Fetal Alcohol Spectrum Disorders | AAFP
    https://www.aafp.org/pubs/afp/issues/2017/1015/p515.html
    Although there is wide variation in the estimated prevalence of FAS/FASD, FAS is thought to occur in 0.3 to 0.8 per 1,000 children in the United States and in 2.9 per 1,000 globally. […] The prevalence of FASD is estimated at 33.5 per 1,000 children in the United States and 22.8 per 1,000 globally. […] In the United States, FASD is least prevalent in Hispanic children and most prevalent in Native Americans and Alaska Natives. […] FAS is diagnosed at an average age of 48.3 months; however, it is commonly missed or misdiagnosed, preventing affected children from receiving needed services in a timely fashion. […] FASD carries a significant economic burden. […] The diagnosis of fetal alcohol syndrome and partial fetal alcohol syndrome is based on defined clinical characteristics and does not require confirmed alcohol use during pregnancy.
  • #109 Fetal Alcohol Syndrome and Fetal Alcohol Spectrum Disorders | AAFP
    https://www.aafp.org/pubs/afp/issues/2017/1015/p515.html
    Diagnosis begins with assessment of prenatal alcohol exposure, including quantity of alcohol consumed per occasion, frequency of use, and timing of consumption during pregnancy. […] The diagnostic criteria for FAS or PFAS do not require confirmed alcohol use if characteristic findings are present. […] However, a confirmed absence of alcohol exposure rules out the diagnoses. […] Confirmation of alcohol exposure is required for diagnosis of alcohol-related neurodevelopmental disorder and alcohol-related birth defects. […] There is no cure for FASD. […] Treatment consists of providing a medical home for the patient and family, managing comorbid conditions, providing nutritional support, addressing behavioral and emotional problems, arranging referrals for habilitative therapies, coordinating care with a multidisciplinary team, and educating parents.
  • #110 Fetal Alcohol Syndrome and Fetal Alcohol Spectrum Disorders | AAFP
    https://www.aafp.org/pubs/afp/issues/2017/1015/p515.html
    Diagnosis begins with assessment of prenatal alcohol exposure, including quantity of alcohol consumed per occasion, frequency of use, and timing of consumption during pregnancy. […] The diagnostic criteria for FAS or PFAS do not require confirmed alcohol use if characteristic findings are present. […] However, a confirmed absence of alcohol exposure rules out the diagnoses. […] Confirmation of alcohol exposure is required for diagnosis of alcohol-related neurodevelopmental disorder and alcohol-related birth defects. […] There is no cure for FASD. […] Treatment consists of providing a medical home for the patient and family, managing comorbid conditions, providing nutritional support, addressing behavioral and emotional problems, arranging referrals for habilitative therapies, coordinating care with a multidisciplinary team, and educating parents.
  • #111 Fetal Alcohol Syndrome and Fetal Alcohol Spectrum Disorders | AAFP
    https://www.aafp.org/pubs/afp/issues/2017/1015/p515.html
    Diagnosis begins with assessment of prenatal alcohol exposure, including quantity of alcohol consumed per occasion, frequency of use, and timing of consumption during pregnancy. […] The diagnostic criteria for FAS or PFAS do not require confirmed alcohol use if characteristic findings are present. […] However, a confirmed absence of alcohol exposure rules out the diagnoses. […] Confirmation of alcohol exposure is required for diagnosis of alcohol-related neurodevelopmental disorder and alcohol-related birth defects. […] There is no cure for FASD. […] Treatment consists of providing a medical home for the patient and family, managing comorbid conditions, providing nutritional support, addressing behavioral and emotional problems, arranging referrals for habilitative therapies, coordinating care with a multidisciplinary team, and educating parents.
  • #112 Fetal Alcohol Syndrome and Fetal Alcohol Spectrum Disorders | AAFP
    https://www.aafp.org/pubs/afp/issues/2017/1015/p515.html
    Diagnosis begins with assessment of prenatal alcohol exposure, including quantity of alcohol consumed per occasion, frequency of use, and timing of consumption during pregnancy. […] The diagnostic criteria for FAS or PFAS do not require confirmed alcohol use if characteristic findings are present. […] However, a confirmed absence of alcohol exposure rules out the diagnoses. […] Confirmation of alcohol exposure is required for diagnosis of alcohol-related neurodevelopmental disorder and alcohol-related birth defects. […] There is no cure for FASD. […] Treatment consists of providing a medical home for the patient and family, managing comorbid conditions, providing nutritional support, addressing behavioral and emotional problems, arranging referrals for habilitative therapies, coordinating care with a multidisciplinary team, and educating parents.
  • #113 Fetal Alcohol Syndrome and Fetal Alcohol Spectrum Disorders | AAFP
    https://www.aafp.org/pubs/afp/issues/2017/1015/p515.html
    Diagnosis begins with assessment of prenatal alcohol exposure, including quantity of alcohol consumed per occasion, frequency of use, and timing of consumption during pregnancy. […] The diagnostic criteria for FAS or PFAS do not require confirmed alcohol use if characteristic findings are present. […] However, a confirmed absence of alcohol exposure rules out the diagnoses. […] Confirmation of alcohol exposure is required for diagnosis of alcohol-related neurodevelopmental disorder and alcohol-related birth defects. […] There is no cure for FASD. […] Treatment consists of providing a medical home for the patient and family, managing comorbid conditions, providing nutritional support, addressing behavioral and emotional problems, arranging referrals for habilitative therapies, coordinating care with a multidisciplinary team, and educating parents.
  • #114 Fetal Alcohol Syndrome and Fetal Alcohol Spectrum Disorders | AAFP
    https://www.aafp.org/pubs/afp/issues/2017/1015/p515.html
    Diagnosis begins with assessment of prenatal alcohol exposure, including quantity of alcohol consumed per occasion, frequency of use, and timing of consumption during pregnancy. […] The diagnostic criteria for FAS or PFAS do not require confirmed alcohol use if characteristic findings are present. […] However, a confirmed absence of alcohol exposure rules out the diagnoses. […] Confirmation of alcohol exposure is required for diagnosis of alcohol-related neurodevelopmental disorder and alcohol-related birth defects. […] There is no cure for FASD. […] Treatment consists of providing a medical home for the patient and family, managing comorbid conditions, providing nutritional support, addressing behavioral and emotional problems, arranging referrals for habilitative therapies, coordinating care with a multidisciplinary team, and educating parents.
  • #115 Data and Statistics on FASDs | Fetal Alcohol Spectrum Disorders | CDC
    https://www.cdc.gov/fasd/data/index.html
    FASDs are a group of diagnoses that can occur in a person who was exposed to alcohol before birth. […] The lifetime cost of care for one individual with FAS in 2002 was estimated to be $2 million. […] It is estimated that the cost to the United States for FAS alone is over $4 billion annually. […] People with fetal alcohol spectrum disorders (FASDs) can experience lifelong issues. […] FASDs last a lifetime. […] There is no cure for FASDs, but research shows that early intervention treatment services can improve a child’s development.
  • #116 What’s New
    https://www.cdph.ca.gov/Programs/CCDPHP/sapb/Pages/FASDs.aspx
    Although FASDs last a lifetime and there is no cure, studies show that treatment services in early childhood can help the child’s development. […] Certain protective factors (i.e., factors that may reduce impact of symptoms) can help reduce some of the effects of FASDs. These factors can help people with FASDs reach their full potential. […] It is important to get help as soon as possible if you think your child may have an FASD or other developmental problem. […] It is important to stop drinking alcohol if you are pregnant or trying to become pregnant. If you are having a hard time not drinking alcohol, you are not alone and help is available. […] It’s never too late to stop alcohol use during pregnancy and it’s important to ask for help.